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Abstract 
 
Drug makers have developed numerous techniques to influence treatment choices.  
Almost no information exists regarding the pharmaceutical industry’s influence on 
rheumatologists and how these pressures could affect patient care.  This 
phenomenological research, conducted within the framework of social exchange theory, 
explored the lived experiences of rheumatologists regarding their interactions with agents 
of the pharmaceutical industry.  A researcher-designed interview protocol was used to 
gather feedback from 10 rheumatologists regarding how interactions with agents of the 
pharmaceutical industry made them feel.  Using horizonalization, meaningful statements 
made by rheumatologists were condensed into specific themes and patterns, which 
provided a composite summary of their experiences with agents of the pharmaceutical 
industry.  The experiences of rheumatologists’ interactions with drug manufacturing 
personnel provided insights about medication access and patient financial assistance.  
Other key themes from rheumatologists’ feedback included relationships, respectfulness, 
value appraisal and credibility, and authority and oversight.  Rheumatologists’ 
preferences and animosities towards the pharmaceutical industry revealed potential 
opportunities to both improve and curtail specific activities.  Such opportunities would 
allow rheumatologists and the pharmaceutical industry to increase equitable exchanges 
and facilitate the appropriate application of medical care for the greater society. 
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Chapter 1: Introduction to the Study 
The pharmaceutical industry is a unique social institution that contributes to the 
larger society by developing medicines and novel treatments to address the medical needs 
of the populace.  Because the pharmaceutical industry and other health care institutions 
must work harmoniously together to apply patient care, the practices and influences each 
has on the other requires constant examination (Appelbaum, 2010).  As such, the 
complex application of medical care in the United States requires impartial scrutiny.  
Though some larger medical specialties, such as cardiology, have enacted policies 
governing ethical relationships between practitioners and pharmaceutical agents 
(American College of Cardiology, 2008), other areas of medicine have yet to examine 
this phenomenon.    
Rheumatology represents one of the smaller medical specialties within the U.S. 
health care system.  Over the last 2 decades, drug manufacturers have developed many 
new treatments for rheumatologic diseases, and this increased innovation has resulted in a 
greater pharmaceutical presence within this specialty (Cronstein, 2007).  As a result, the 
influence drug manufacturers apply to these practitioners has raised new questions 
regarding equitable exchanges and what represents ethical interactions (Cronstein, 2007).  
Interestingly, such questions persist without definitive guidance as to what an appropriate 
relationship is in rheumatology or how such interchanges can impact the care 
rheumatologists provide for their patients.  
Equitable exchange between health care partners represents an important social 
imperative for each culture.  Any negative impact one organization may have on another 
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could increase the adverse health outcomes of the population it serves (Eichler, Abadie, 
Raine, & Salmonson, 2009).  Given the implications of these processes, equitable 
exchanges must be identified and understood to ensure that the health of the larger 
society remains thoroughly intact (McClure, 2009).  This research seeks to understand the 
influence of the pharmaceutical industry on rheumatologist’s patient care as doing so will 
elucidate a framework of processes and opinions by which exchanges between these two 
groups can be understood. 
Background of the Study 
Health care is a fundamental requirement of each society to ensure that the 
function of each member is maintained.  The appropriation of medical care often requires 
multiple professionals, each coordinating a specific function to deliver a necessary 
service.  Given the dependence each populace has on this matrix, the unobstructed flow 
of information between these partners remains critical (Kirschenbaum, 2009; Krumholz, 
Coutts, Angell, & Gottlieb, 2009).  Physicians require medicines to treat illnesses, drug 
makers seek new treatment interventions to ameliorate diseases, and the greater public 
expects each party to work together to maintain and improve the overall health of the 
populace.  It is when the acquisition of wealth takes precedence over ethical medical care 
that the social exchange between these groups becomes inequitable (Appelbaum, 2010; 
Crigger, Barnes, Junko, Rahal, & Sheek 2008; Kerridge et al., 2005; Olsen 2009).  
Appelbaum (2010) explained that these relationships demand the uninterrupted flow of 
critical information to advance medicine so practitioners can make appropriate treatment 
decisions.  Thus, the relationships between social institutions in health care represent an 
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information network, with each party requiring something from the other in order to 
fulfill its mission. 
Drug makers have developed numerous techniques to influence treatment choices 
(Crigger et al., 2008; Fischer et al., 2009; Kerridge et al., 2005; Nur & Ozsahin, 2009; 
Olsen & Whalen, 2009).  Perhaps the most effective mechanism to drive drug selection is 
that which bounds the confines of a relationship (Appelbaum, 2010; Krumholz et al., 
2009).  Some form of partnership is necessary between health care matrix partners 
because the flow of pertinent information is critical to the advancement of patient care 
(Appelbaum, 2010; Kerridge et al., 2005).  However, many have sought to limit such 
exchanges in order to reduce the perception of bias or influence over treatment selection 
(Naik, Woofter, Skinner, & Abraham, 2009; Olsen, 2009).  
Given the need for regulatory oversight, many national governments have 
imposed laws and regulations to ensure that the application of medical care remains 
harmonious.  In the United States alone, the Health Insurance Portability and 
Accountability Act (1996) and the Anti-Kickback Statute (1972) became law in order to 
preserve equitable interactions between medical professionals and their contractors 
(Appelbaum, 2010).  In addition to these and other federal mandates, individual states 
have also executed laws governing the interactions between health care workers and 
agents of the pharmaceutical industry.  Even some professional medical societies adopted 
guidelines or governing principles regarding relationships with drug manufacturers 
(American College of Cardiology, 2008).  Though each policy provides 
recommendations and statutes to regulate collaborations with the pharmaceutical industry, 
the aim of action was to ensure transparency (Eichler et al., 2009; Kerridge et al., 2005). 
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Perhaps the most disputed matter regarding the relationship between physicians 
and drug makers is that of reciprocal influence (Fischer et al., 2009; Krumholz et al., 
2009).  Although the resulting relationship between these parties seems inevitable, 
defining positive and negatives levels of influence are often relegated to the perceived 
outcomes of these relationships (Appelbaum, 2010; Christensen, 2009; Crigger et al., 
2008; Fischer et al., 2009; Krumholz et al., 2009).  Scholars have examined various 
outcomes, such as patient health, monetary incentives, and perceived information bias 
(Appelbaum, 2010, Christensen, 2009, Fischer, et al., 2009).  However, less emphasis is 
afforded to practitioner perceptions of pharmaceutical influence, in part because 
physicians face many groups who believe any level of this relationship injects potential 
proclivity (Eichler et al., 2009). 
Often, individual awareness of influences between physicians and drug makers is 
subtle, but becomes subjective when reviewed by a third party (Olsen & Whalen, 2009, 
Parker, 2007).  In fact, the growing body of evidence exploring such relationships is often 
generated by such third parties, such as patient advocacy groups, managed care 
organizations, and professional medical societies (Fischer et al., 2009; Kerridge et al., 
2005).  Although the physician perspective regarding the influence of the pharmaceutical 
industry accompanies this book of knowledge, such findings are often presented through 
opinion polls and in the first person (Nakayama, 2010).  Moreover, little if any such 
analyses exist within the therapeutic space of rheumatology.   
It is important to determine the level of influence of drug makers from the 
practitioners’ perspective.  Understanding these lived experiences provides transparency 
for physicians and pharmaceutical organizations alike (Appelbaum, 2010, Crigger, et al., 
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2009, Krumholz, et al., 2009).  In this study, I examined the effects of the pharmaceutical 
industry on rheumatologists’ patterns of patient care.  Quality health care affects all 
members of the populace.  Though equitable exchanges between collaborators are subject 
to individual perceptions and value domains, interchanges that result in diminished 
patient care must be examined in order to elucidate positive change (Fischer, et al., 2009).  
Pharmaceutical organizations may seek to influence physician prescribing, but doing so 
may cause practitioners to choose suboptimal treatments, leading to diminished outcomes 
(Krumholz, et al., 2009).  Therefore, medical processes that impinge the ethical 
application of patient care must be elucidated if the equitable function of a given health 
care systems is to be maintained.   
Problem Statement 
 
 Considerable evidence exists on the potential negative influence that drug 
manufacturers may have on physician prescribing habits (Appelbaum, 2010; Crigger et 
al., 2008; Eichler et al., 2009; Fischer et al., 2009; Kerridge et al., 2005; Krumholz et al., 
2009; Naik et al., 2009; Nakayama, 2010; Nur & Ozsahin, 2009; Parker, 2007; Sah & 
Fugh-Berman, 2013).  Appelbaum (2010) and Nur and Ozsahin (2009) referenced the 
reciprocal influence that drug manufacturers may have on physician prescribing habits, 
while Crigger et al. (2009) and Fischer et al. (2009) detailed the mechanisms in which 
these organizations may leverage only favorable data in educational settings.  Regardless 
of the mechanisms employed by pharmaceutical organizations, many physicians and 
professional societies reject that such means will sway what drug they decide to use in a 
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given situation (Kerridge et al., 2005; McClure, 2009).  However, there is little to no 
information on this topic in the therapeutic discipline of rheumatology. 
 There is conflicting evidence on the pharmaceutical industry’s effect on 
rheumatologists’ patterns of patient care.  Though both health care collaboration partners 
play a role in the application of medical care, increasing exposure to rheumatologists by 
the pharmaceutical industry has generated new questions about reciprocal influence.  In 
previous studies on physician perceptions of the pharmaceutical industry, researchers 
revealed distrust and skepticism regarding drug agent motives (Crigger et al., 2008; 
Fischer et al., 2009; Kerridge et al., 2005; Nur & Ozsahin, 2009; Olsen & Whalen, 2009).  
Scholars also revealed increasing interdependence for information exchange between 
physicians and pharmaceutical representatives when exchanges intensify (Kirsch, 2010; 
Rodwin, 2010).  However, such research was limited to a broad spectrum of physicians, 
often primary care, and did not address the potential impact such exchanges may have on 
smaller therapeutic specialists who have only been engaging industry representatives for 
a short period of time.  
 When considering the topic of reciprocal influence between two parties, the 
concept of equity and fair balance become subjective. Appelbaum (2010) explained that 
interactions between physicians and drug manufacturers might result in multiple forms of 
collaboration, each with varied equitable exchanges that could result in either improved 
patient care coordination or negative health outcomes for patients.  Though rheumatology 
represents a small specialty physician discipline, over the last decade, these practitioners 
have been propelled to the forefront of modern medicine with the introduction of 
numerous innovative biologic medicines (Naik et al., 2009).  As a result, the 
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pharmaceutical industry’s presence in rheumatology has grown precipitously, leading to 
many new questions regarding the influence this group has on practitioners’ methods of 
applying patient care and what exchanges represent equitable practices.  Crigger et al. 
(2008), Kerridge et al. (2005), and Olsen and Whalen (2009) indicated that drug makers 
can effect practitioner habits in a variety of ways and understanding the impact such 
processes may have on patient care must be elucidated in order to identify appropriate 
areas of ethical and equitable exchange.  Hence, in this study, I explored the lived 
experiences of rheumatologists regarding the pharmaceutical industry’s effect on their 
patterns of patient care.  
Purpose of the Study 
 The purpose of this study was to examine the lived experiences of 
rheumatologists regarding the effect of the pharmaceutical industry on their patterns of 
patient care.  Through this qualitative study, I gained insights regarding the influence of 
drug makers on rheumatologists and how this has impacted the care these practitioners 
provided for their patients.  Because such research has yet to be conducted, the findings 
from this inquiry can inform rheumatologists, leadership within the pharmaceutical 
industry, government regulatory agencies, managed care organizations, and patients as to 
whether there is an advantageous or adverse cost benefit exchange between drug 
manufacturers and rheumatology practitioners.  Positive exchanges can be identified and 
improved upon, whereas negative processes can be determined and amended to facilitate 
the appropriate application of medical care for the greater society.  
Research Question 
 The following question informed this research study: 
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1. What are rheumatologists’ lived experiences regarding the influence of the 
pharmaceutical industry on their pattern of patient care? 
Conceptual Framework 
The contextual framework for this study concerned the influence individuals have 
on one another and how these relationships impact outcomes.  Personal relationships 
derive from an innate desire to exchange experiences and to reap rewards of satisfaction 
and trust (Thibaut, 1986).  As such, social exchange theory is a platform that can be used 
to describe the ascendance of relationship formation and why such connections become 
significant.  Because each individual develops goal-oriented behaviors as a result of 
social exchange, this medium provides a conceptual lens in which to explore individual 
influence over others (Ekeh, 1974).  Because each society seeks to evolve and 
incorporate more complex interaction structures and institutions, the equality and 
morality of each exchange becomes a social issue (Cook & Emerson, 1987).   
Interpretation of the lived experiences of one group regarding their exchange 
relationship with another requires context and boundaries that allow each member to 
consider his or her individualistic value perspective.  When such perspectives become 
shared across a community, it becomes an institutionalized process, further increasing 
each member’s exchange potential (Blau, 1986).  These institutionalized groups then 
develop values and norms to regulate goal-oriented exchange possibilities, and these 
processes become ingrained as operational procedures and serve to socialize each 
member (Thibaut, 1986).  Although an institution is representative of a specific culture, 
its processes may influence others to change or create various obstacles when exchanges 
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are performed without its involvement (Thibaut, 1986).  Such is the case when a specific 
group wishes to influence, integrate, or dominate others. 
Within the confines of this research, the pharmaceutical industry represented one 
such institutionalized group that often exploits its influence over medication prescribers 
to achieve financial goals.  The mechanisms permitting such inducements are 
circumscribed to social exchange situations, with each interaction resulting in greater 
influence (Blau, 1986).  Although many argue the leverage of formed relationships may 
be equitable for those involved in a given exchange, the outcome may not always 
facilitate improvements for the greater society (Bignoux, 2006; Cook & Emerson, 1987; 
Ekeh, 1974).  A physician and a drug representative may have a respected affiliation, but 
if actions emanating from this association adversely affect patients, then the 
interrelationship creates unwanted imbalances.  Social exchange theorists explain that the 
use of influence is at the heart of each interaction because each exchange partner enters 
into the relationship wanting something from the other (Blau, 1986; Cook & Emerson, 
1987; Ekeh, 1974; Thibaut, 1986). 
In this study, I sought to understand the lived experiences of rheumatologists 
regarding the pharmaceutical industry’s influence on their patters of patient care.  Each 
party willingly enters into periodic social exchanges while developing a sphere of 
influence over the other (Cook & Emerson, 1987).  Over time, the impact of these 
exchanges may guide or sway decision making to favor one collaborator over another.  
The impact of reciprocal exchanges over time may be subtle, and at times seem amicable, 
especially when both parties achieve their desired goals (Blau, 1986).  Understanding the 
experiences of rheumatologists regarding their exchange relationship with drug 
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manufacturers could provide insights for leaders within the pharmaceutical industry 
regarding the reciprocal influence each group has on the other. 
Nature of the Study 
 This qualitative research will explore the influence pharmaceutical manufacturers 
have on the care rheumatologists provide to their patients.  Creswell (2007) explained 
that qualitative researchers seek to understand the meaning that individuals ascribe to a 
given situation or circumstance.  The purpose of this study was to understand the lived 
experiences of rheumatologists regarding the effects of drug manufacturers on their 
pattern of patient care.  The interpretation of those experiences requires the accumulation 
of a broad medium of value-oriented behaviors, individualistic goals, and the moral 
perspective of the presiding societal culture.  If the outcomes of these exchange 
transactions appease the societal role facilitation of each party, then a thorough 
understanding of these experiences provides a platform in which to interpret additional 
exchanges (Blau, 1986).  
 Given the breadth of potential individual empiricism, a qualitative study design is 
amenable to explore the lived experiences of study participants.  A phenomenological 
study design was selected to elucidate the shared experiences of rheumatologists 
regarding the influence of pharmaceutical corporations on their patterns of patient care.  
In doing so, I aimed to determine what these lived experiences are and how these 
outcomes have influenced their patient care.  The focus on the essence of these lived 
experiences distinguishes the phenomenological approach from other qualitative research 
approaches.   
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Definition of Terms 
 Rheumatology: A distinct therapeutic area of medicine that diagnoses, treats, and 
medically manages patients with arthritis and other rheumatic diseases (American 
College of Rheumatology, 2012).  
 Social exchange theory: Examines socially motivated reciprocal processes 
between individuals, organizations, and cultures to achieve specific outcomes (Blau, 
1986). 
Assumptions 
 In this study, I explored the effects of the pharmaceutical industry on 
rheumatologists’ patterns of patient care.  The following assumptions were considered: 
1. The participating rheumatologists in this study have undergone 
interactions with various pharmaceutical personnel. 
2. The participating rheumatologists prescribe medicines promoted by drug 
manufacturers for their patients. 
Scope and Delimitations 
Scope 
In this study, I explored the lived experiences of rheumatologists regarding the 
pharmaceutical industry’s effect on their patterns of patient care.  To date, there is no 
empirical evidence suggesting that such an influence exists, but the philosophical 
underpinnings of social exchange theory propose that all interchange partners affect each 
other (Blau, 1986).  Although scholarly evidence of drug manufacturer influence is 
present in other medical arenas, rheumatology has yet to be explored.  Social exchange 
theory provides a conceptual framework to explore how individuals or groups apply 
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influence on each other before, during, and after various interchanges.  The qualitative 
nature of this exploration allowed rheumatologists to explain their exchange experiences 
with various agents of drug manufacturers to determine if reciprocal active or passive 
influence exists.  Understanding the impact of these lived experiences can provide 
context for both exchange parties and aid in the construction of an improved equitable 
relationship. 
Delimitations 
This research encompassed the live experiences of rheumatologists and their 
opinions regarding the influence that the pharmaceutical industry has had on their patters 
of patient care.  As such, participants were delimited to rheumatologists and not to other 
practitioners in different areas of health care.  These health care professionals are trained 
in primary care, but undergo specific training in rheumatologic care and are, therefore, 
separated by this specialization.  As such, the boundaries of this inquiry were confined to 
this specific health care population.  Although the conceptual framework encompassed by 
this research may be transferable to other areas of medicine, the nuances and professional 
variations between these groups would require separate analyses.  
Limitations  
 Potential limitations of the study included the following: The discussion of each 
limitation impact is detailed in Chapter 3 of this manuscript. 
1. Because I explored the lived experiences of only 10 rheumatologists in the 
Southeast United States, the resulting themes and insights may not be 
generalizable across the entire field of medicine. 
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2. I explored the reciprocal relationship between drug manufacturers and 
rheumatologists from the perspective of the participating rheumatologists.  
Therefore, the outcomes may not reflect the perspective of the 
pharmaceutical industry. 
Significance of the Study 
Significance to Practice 
Each society must construct mechanisms to ensure the viability of its population.  
Health care is a vital institution within this context and requires collaboration between 
multiple members of the populace.  Medical professionals play a role in the application of 
health services, and issues related to patient care must take priority over personal 
considerations (Crigger, et al., 2009).  As such, relationships between exchanges partners 
must promote medical improvements if each member is to fulfill the given societal role 
they occupy (Appelbaum, 2010; Eichler et al., 2009; Krumholz et al., 2009).  Therefore, 
understanding the influence each group has upon the other may elucidate practices that 
can be improved upon to potentially foster positive health outcomes. 
Significance to Theory 
Maintaining the health of a given population is a critical societal imperative and is 
necessary for continued viability and evolution.  However, the mechanisms that influence 
its application are multifaceted and may differ from one population to the next.  Because 
the practice of medical care involves multiple individuals engaging in a variety of 
exchanges in order to achieve a desired outcome, each becomes influenced by the other 
(Blau, 1986).  Though the impact of each exchange may seem subtle, continued 
exchanges between individuals or organizations require trust and equitable arrangements 
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(Cook & Emerson, 1987).  While exchange mechanisms help shape different social 
norms, various constraints existing within each cultural matrix may attenuate or confine 
such processes. 
 Though trust and reliance are required for each party to engage in a particular 
transaction, the evolving process of reciprocal exchange increases the dependence 
between them.  While profit-motivated behaviors abound in free markets around the 
world, the actual remuneration may be more relative than absolute (Cook & Emerson, 
1987). As each exchange partner strives to exchange commodities that maximized gains 
while minimizing losses, attainment could lead to either gratification or disappointment, 
depending on the circumstances encompassing that exchange (Blau, 1986).  These 
profit/loss motives can lead to coercive practices and negative outcomes, even when such 
conclusions were not intended.  
Significance to Social Change 
In this study, I examined the lived experiences of rheumatologists regarding the 
effect of the pharmaceutical industry has on the care provided to their patients.  Through 
this qualitative study, I gained insights regarding what influences drug makers have on 
rheumatologists and how this has impacted their approach to patient care.  Because such 
research has yet to be conducted, the findings from this inquiry can inform 
rheumatologists, drug manufacturer leadership, government regulatory agencies, 
managed care organizations, and patients as to whether there is an advantageous or 
adverse cost benefit exchange.  Positive exchanges can be identified and improved upon, 
whereas negative processes can be identified, categorized and amended to facilitate the 
appropriate application of medical care for the greater society. 
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Summary and Transition 
 Because health care requires the coordination between many different individuals, 
each transactional exchange should serve to facilitate patient care.  For this reason, it is 
necessary to explore these value-oriented interactions in order to determine the depth of 
influence one party has over the other.  Individual, organizational, and societal influences 
may alter such intent and lead to impediments for medical care.  According to the social 
exchange process, such impediments can and often lead to conflict or social restriction of 
the interchange involved.  It then becomes a societal mandate to determine what 
restrictions or deterrents exist within an exchange matrix so as to determine what 
processes can be altered or modified to form equitable interchange.   
 In this study, I sought to understand the lived experiences of rheumatologists 
regarding the influence that the pharmaceutical industry has had on the care they provide 
to their patients.  Through this inquiry, I sought to understand what reciprocal 
consequences exist and how subjects are or are not influenced by agents of drug 
manufacturers.  In addition I elucidated what the connections are and how these processes 
work.  In doing so, a greater understanding of drug manufacturers’ motivations can be 
examined and interpreted regarding this evolving health care relationship.   
Chapter 2 provides a comprehensive literature review, Chapter 3 includes a 
description of the methodological approach for this inquiry. In Chapter 4, I describe the 
research findings, and Chapter 5 includes the interpretation of the data.  
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Chapter 2: Literature Review 
Introduction 
 There is conflicting evidence regarding the pharmaceutical industry’s effect on 
rheumatologists’ patterns of patient care.  Crigger et al. (2008), Kerridge et al. (2005), 
and Olsen and Whalen (2009) indicated that drug makers can affect practitioner habits, 
and it is necessary to understand the impact such processes have on patient care in order 
to identify areas of ethical and equitable exchange.  Hence, in this study, I explored the 
lived experiences of rheumatologists regarding the pharmaceutical industry’s effect on 
their patterns of patient care.  Because the actual effect drug companies have on 
rheumatologists’ practice decisions are relatively unknown, understanding this impact 
could provide insights for pharmaceutical processes to align corporate goals with the 
needs of this specialized discipline. 
 In this literature review, I summarize research related to social exchange practices 
and how societal members and social institutions engage in interactions that evolve over 
time.  Because the confines of this philosophical framework provide insights regarding 
reciprocal processes of interdependent relationships, it allows for a detailed analysis of 
motives and value-oriented behaviors between exchange partners.  In addition, I will 
consider the social norms that bound an exchange environment as well as the potential 
consequences of inequitable reciprocation. 
Literature Search Strategy 
 The information presented in this review was collected using multiple means.  
First, the theoretical framework was examined through the works of Blau (1964), Cook 
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and Emerson (1987), Ekeh (1974), and Thibaut (1986) as they relate to the different 
elements of social exchange theory.  Sources for the literature review were obtained 
through a database review, including Academic Search Premier, Google Scholar, 
ProQuest, numerous scientific journals, Walden Dissertations, and local library resources 
like the book sharing programs throughout various academic institutions in the state of 
Georgia.  Because the presence of pharmaceutical representatives has increased in 
rheumatology over the last decade (Cronstein, 2007), the parameters for the literature 
search were limited to those published no more than 10 years ago.  Keywords used to 
mine these and other databases included the base phrases social exchange, social 
exchange theory, equitable corporate sharing, pharmaceutical ethics, physician and 
pharmaceutical, pharmaceutical processes, and corporate responsibility.   
Various terms, such as pharmaceutical, rheumatology, ethics, equality, and 
leadership, were used to condense the large amount of data discovered by the base phrase 
searches.  The purpose of this research strategy was to use the broad phrase searches to 
maximize the return of scholarly journals and periodicals.  Reviewing the extensive 
returns of these searches often revealed unanticipated and useful materials.  In addition, 
collaboration with professional colleagues, student peers, and Walden professors 
provided other recommended sources of information, such as websites (e.g., PhRMA.org 
and Pharmaceuticalethics.com) and pharmaceutical mission statement review. 
 I incorporated the philosophical works of several key scholarly authors, each 
contributing to the consensus of the social exchange intellectual framework.  Blau, Cook, 
Ekeh, and Thibaut provided an examination of the theoretical structure for this research, 
which also encompassed practical examples of social exchange situations, serving to 
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further influence the literature search.  Many of the social exchange-derived scholarly 
journals quoted and cited the above authors and described their literary contributions as 
the foundation for social exchange composition.  I made notes throughout the review of 
each of these published works. 
Though ample literature was available regarding pharmaceutical tactics with 
regards to physicians profiling and suggestive marketing practices, little information 
regarding the social exchange mechanisms employed by drug manufacturers was found.  
Instead, the wealth of evidence available is often the result of third party observation, 
many of which view any relative exchange between physicians and members of the 
pharmaceutical industry as questionable.  Specifically, Appelbaum (2010), Crigger et al. 
(2008) and Kerridge et al. (2005) referred to such exchanges as an open-ended potential 
for discourse.  Each provides examples of pharmaceutical interactions with physicians as 
a trade of commodities, regardless of whether the information is educational, monetary, 
or influential.  From this perspective, a physician willing to engage an agent of the 
pharmaceutical industry is subject to the value domains of anyone who oversees or 
reviews the interaction. 
In rheumatology-specific searches, I found some scholarly information regarding 
interactions with drug company personnel, but the boundaries of equitable exchange 
confining such interactions were not elucidated.  Cronstein (2007) explained that the 
notion of incorporating pharmaceutical support or attendance does not necessarily mean 
rheumatologists become unknowingly influenced.  Furthermore, if a rheumatologist pays 
for a meal with a representative of a drug manufacturer, it may not mean the 
pharmaceutical employee has become influenced by the doctor (Cronstein, 2007).  The 
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assumed dominion drug companies have over rheumatologists is not evidence-based 
(Lipsky, 2009).  As such, the value domains that encompass exchanges between these 
collaborators remain unclear, and the resulting influence each party has on the other is 
entirely subjective.  The void in this body of knowledge influenced the pursuit of this 
research. 
Theoretical Foundation  
Foundation of Social Exchange 
 Throughout human history, social behavior has been relegated to observational 
scrutiny rather than scientific fact (Cook & Emerson, 1987).  Historically, scholars 
reviewed documents and artifacts to gather evidence on social outcomes, but it was not 
until the mid-19th century that sociological aspects of human behavior were actively 
observed and categorized (Ekeh, 1974).  The industrial revolution gave way to the 
information age and shifted the social perspective away from authoritative and 
aristocratic rule to an economy based on exchange of labor for wages, often isolating 
workers from the support and certainty of the familial trades (Blau, 1986).  Through this 
evolution, many societies began to prosper and grow at a rate not seen before in human 
history.  The increasing exchange of ideas, commodities, and labor began to shape each 
culture and lead to increased collective action by each society (Ekeh, 1974). 
 Human interaction is the result of many different types of associations.  Individuals 
may be associated through relationships involving family, labor, recreation, proximity, 
conflict, or shared cultural beliefs (Blau, 1986).  Through these associations, a complex 
system of exchanges develops in which wealth, status, power, or psychological 
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fulfillment are increased or decreased.  Such exchanges are the result of opposing forces, 
which creates balances and imbalances (Blau, 1986).  A person gaining a particular 
resource often results in the limitation of another to obtain the same commodity.  
However, social exchange practices evolved to create more equitable practices in which 
such resources may be exchanged for another, perpetuating a system of continuous 
interchange and dependency. 
 Although historical evaluation of social exchange often provides evidence of only 
value acquisition, interchanges involving personal relationships were more difficult to 
scrutinize.  As members within a certain social matrix may or may not have access to 
various resources, socially motivated exchanges may predominate.  Within each society, 
individuals become indoctrinated into the system of social exchange soon after birth 
(Blau, 1986).  From the moment a toddler assigns value to a given object or act, he or she 
begins to develop psychological methods of acquiring it (Cook & Emerson, 1987).  The 
more the object or action pleases the child, the greater the value assigned to it.  Once the 
child is able to speak, new methods of manipulation begin, and the reciprocity of 
appeasing these desires leads to the formation of different values, goals, and preferences 
(Cook & Emerson, 1987). 
 As societal members mature through life and develop new relationships to facilitate 
social exchange processes, larger organizations form to perpetuate such actions.  As a 
result, families, communities, businesses, organizations, societal infrastructure, and 
governments begin to take shape, each serving to increase exchange possibilities.  
Exchange processes learned throughout life develop into goal-oriented behaviors as 
individuals seek to create personal satisfaction, regardless of its designation (Thibaut, 
 
21 
1986).  Each social exchange theorist agrees that the acquisition of power, love, wealth, 
or personal fulfillment becomes contingent on the actions of others.  As such, societal 
members find profit in their interactions with others, although the allocation of this 
benefit is not always equal (Blau, 1986).  The motives behind these pursuits are often 
rewards gained from psychological processes of attraction, both physical and nonphysical 
(Thibaut, 1986). 
Examples of Social Exchange 
 Though basic survival necessitates various exchanges between individuals in 
primitive society, the evolution of social structures became a critical component of 
interchanges between citizens of a given community.  Ekeh (1974) denoted the diffusion 
of organized religion as a modality that served to exchange information and societal 
values between indoctrinated members.  Once initiated into a given religious structure, 
each individual is encouraged to recruit new members to facilitate increased exchange 
possibilities, which lead to the expansion of that cultural organization (Cook & Emerson, 
1987).  Because this system is self-perpetuating, it requires increasing dependence to 
exert its significance.  Individual needs are superseded by the needs of the growing 
movement, but still remain the underlying motivation for each member (Ekeh, 1974). 
 Religion is but one social structure emerging to facilitate greater social exchanges.  
Although the commonalities shared by each member provide a base for increased 
interactions, the structural framework of the societal structure does not specifically feed 
or protect its members (Thibaut, 1986).  Instead, it serves as a cultural attribute, in which 
members identified themselves as part of; worthy of preservation, and in some cases, 
domination.  This dependability influences the development of other social structures, 
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each inculcating new values and opportunities for exchange between each individual.  As 
each societal structure evolves, its infrastructure creates new positions in which members 
can aspire to, thereby expanding exchange possibilities.  Other commodities, such as 
improved accommodation, wealth, and power, often accompany ascendance within the 
social organization.  Once established, the social order is able to apply value to its 
existence beyond the shared commonalities of its members (Ekeh, 1974). 
 As the benefits of evolving social organizations demonstrate value to each of its 
members, individual needs and exchanges have to benefit the larger social order so as to 
sustain its increased proliferation (Cook & Emerson, 1987).  Although the actions of each 
citizen serve the larger populace, individual motivations for such exchanges evolve from 
direct to indirect (Ekeh, 1974).  Instinctual desires previously influencing particular 
actions give way to learned exchange practices, which benefit each party.  A member of 
society seeking food learns directly that taking it from another nullifies an exchange, 
whereas negotiation or exchange engagement creates an opportunity for continuous trade 
(Blau, 1986).  Because the value of the relationship now outweighs the potential for one-
time gain, a social code of conduct emerges to facilitate increased exchange while 
creating reparation for self-serving conduct (Ekeh, 1974). 
 As society evolved further, the domains by which individuals could engage in 
exchange activities increased.  These various influences created new socially conditioned 
situations, often leading to economic pursuits rather than individualistic survival 
motivations (Ekeh, 1974).  As social conditions became more economically ambitious, 
members increasingly sought social exchanges to maximize profit potential, while 
minimizing potential loss.  As humans learned the value of profit, economic motivations 
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became commonplace and created new social norms to separate exchanges of necessity 
into modes of transactions (Thibaut, 1986).  However, growing social systems 
perpetuating economic growth required controlling forces to prevent conflict and 
harmonize a system of balances (Cook & Emerson, 1987).  As such, new social norms, 
influenced by familial, community, and governmental systems, developed to regulate 
social exchanges (Blau, 1986). 
Conceptual Framework 
Philosophical Assumptions of Social Exchange 
 Society is a complex blend of individuals collaborating amongst others to achieve a 
wide variety of goals.  From birth, individuals begin the ritual of social indoctrination and 
learn quickly to assign value to attributes that create pleasing emotions (Cook & Emerson, 
1987).  Because the stimulus of social interaction increases as a person matures from 
youth, the constructs of individual value sets begin to shape into a hierarchical system.  
Within this system, people learn to place various levels of value on things, which in turn 
are assigned worth (Thibaut, 1986).  Once a general sense of worth forms physical and 
emotional characteristics, the individual learns his or her value in social exchange 
situations (Cook & Emerson, 1987).  From there, socially conditioned members engage 
in multiple exchange processes to maximize gains and to seek physical and emotional 
fulfillment (Blau, 1986). 
 Because the value of a thing is mediated by hypothetical constructs created by the 
individual, its relative worth varies among the social players.  Some will place paramount 
value on a thing and seek to exchange physical or emotional favors to possess it, whereas 
others may apply low worth (Ekeh, 1974).  As a result, an array of social exchanges 
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becomes possible with members actively interacting and perpetuating countless 
transactions.  The sheer diversity of human relations creates revolving processes, which 
shape individual choices and preferences, while influencing external conditions which 
become socially modified to increase exchange possibilities (Blau, 1986).  As new 
members become assimilated into a given society, they introduce new exchange choices, 
shape new motivations, and alter social norm conduct to favor desired conditions (Blau, 
1986). 
 Individuals may not always be able to acquire their desires and may become willing 
to use coercive actions to obtain it.  However, social indoctrination may influence 
individual gain to favor that of a group or specific segment of the population.  Such is the 
case when individuals form units to greater facilitate each individual’s need for social 
exchange, but also to further common goals.  Practically every group in society has goals 
to create self-propagation and continuous development (Thibaut, 1986).  Clubs, gangs, 
classes, communities, religions, and governments each have agendas and needs, whose 
members serve the unit by identifying, acquiring, and expending resources to expand its 
fulfillment (Cook & Emerson, 1987).  Individual friendships also serve this common goal 
through social exchange processes by rewarding each member and providing the 
necessary incentive for continuous development (Thibaut, 1986). 
 Although various exchange processes create unions between societal members, not 
all transactions are equal.  Some may argue different social norms reward actions that 
maximize benefit through the quest of power or status differentiation, rather than 
propagate harmony through equality.  Ekeh (1974) explained that such pursuits are not 
always economically influenced, but are often symbolic.  Exchange processes may lead 
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one individual to obtain objects that have low value to the majority, but have high 
emotional overtones for those who possess it.  Ekeh (1974) exemplified these behaviors 
by denoting a person’s willingness to exchange monetary commodities for a religious 
artifact, perhaps having virtually no value for the social majority.  It is within the 
individual’s psychological constructs that value becomes weighted, leading him or her to 
seek out emotional fulfillment. 
 Because the psychological constructs of a given exchange may differ between 
interchange partners, the morality of the experience may define the boundaries governing 
the process (Blau, 1986).  Each participant receives fair and balanced rights for the 
exchange whereas self-interest cannot prevail for the majority.  Ekeh (1974) explained 
that such morality exists in social exchanges even when under the influence coercive 
forces.  A dictator could impart fair judgment of an exchange between subjugated citizens 
when nothing is at stake for them.  However, coercion is a common mechanism for 
individuals to implement when they wish to obtain something they value in the absence 
of equal exchange (Zhang & Epley, 2009).  Thibaut (1986) suggested that the presence of 
such inequalities creates changing imbalances in society, with opposing forces 
exchanging power continuously to seek equilibrium.  Blau (1986) explains societal 
balance is a necessary cornerstone for equitable social exchange because fewer 
impediments exist to distract individuals from continuous trade. 
 Within this changing environment, many people develop similar desires and take 
similar steps towards its acquisition.  Because social exchanges are mediated through a 
variety of different relationships, individuals learn to seek out those with kindred traits to 
facilitate greater interaction.  As groups form and membership increases, organizations 
 
26 
develop to optimize exchanges and participants learn to induce desired actions from 
outside members (Cook & Emerson, 1987).  If an outsider is unwilling to conform to the 
constructs of the association, in-group members invoke disapproval and often restrict 
exchange opportunities with them (Zhang & Epley, 2009).  Inevitably, both parties will 
conduct exchange processes on different levels, but will assign contrasting values for 
things they believe have greater worth. 
 Although kinships with like individuals may facilitate greater social exchange 
possibilities, it does not mean all members of society seek such relationships.  In a free 
society where individual choice prevails over directed social activity, endless possibilities 
emerge for social conduct and create abundant opportunities for exchange processes 
(Blau, 1986).  Each individual develops social and psychological constructs that drive 
individual choice and justify personal needs.  They are also free to associate with other 
members who may or may not have similar traits.  This expands the person’s ability to 
engage in exchange processes that would not be otherwise available in a restrictive state.  
As a result, each member involved experiences different opportunities and challenges to 
facilitate social exchange processes and seeks personal fulfillment through a variety of 
means afforded within their social construct (Cook & Emerson, 1987). 
Challenges of Social Exchange 
 Historically, social exchange processes were necessary to obtain basic needs and 
improve livelihood.  Once basic necessities were assured, more complex exchanges 
emerged to fulfill other aspects of social development.  However, due to the limited array 
of individual possessions, exchange processes did not always benefit those involved.  
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Rosenbaum (2009) explained parents exchanged children, among other commodities, 
through marriage to ensure prosperity or balance opposing forces in conflict.  In doing so, 
the children are denied the freedom of social exchange, whereas the families controlling 
the union obtain some level of fulfillment.  Furthermore, the persons involved are often 
conditioned to accept the terms of the union, often forgoing individual freedoms to accept 
new exchange possibilities promised through the terms of their sacrifice (Nakonenzy & 
Denton, 2008).  Even with abundant resources available for exchange today, such 
practices still exist because the value of the exchange is given priority over other 
possessions. 
 Such are the challenges of social exchanges that each potential commodity has 
presumed value and those seeking it will may employ a variety of means to acquire it.  To 
further complicate matters, the actual value of the exchange may be disproportionate 
between those engaged in the activity, where one individual may place high value and 
another places low value.  Blau (1986) explained such circumstances created preludes to 
conflict because an individual who places high value on a commodity may employ 
unscrupulous means of acquisition, even when the value to others is relatively low.  Cook 
and Emerson (1987) denoted these processes in social exchange situations might create 
avenues of potential exploitation, deceit or perfidiousness.  As these practices grow, 
conflict often ensues in an effort to achieve balance for future exchanges. 
 Though conflict can emerge through social exchange practices, outcomes can lead 
to improved systems that serve to create equitable practices during such processes.  A 
common development leading to potential balance is the enactment of socially 
conditioned laws and governances.  As society develops and agrees upon the value of 
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common exchange practices, this acceptance provided the foundation for rules to govern 
the overall process.  Thibaut (1986) expressed this development is exemplified in 
common social marketplaces, where commodities are sold to customers with standard 
costs or trade.  In this matrix, each citizen agreed on the value of a particular ware and 
voluntarily participated in the fair exchange process.  It is when the value of a commodity 
is unknown or novel that its reimbursement in an exchange became questionable or 
controversial. 
 Ekeh (1974) explained the foundation in which individuals engaged in social 
exchange was built primarily on trust and the ability to opt out of the process if they 
deem its reimbursement was unfair.  When trust and reliability become insured, other 
socially conditioned processes emerged and gained value among the actors involved.  
Camaraderie, friendship, love and appreciation are possible outcomes of positive social 
exchanges once the process created greater investment than the simple commodity 
involved in transfer.  Persons may agree to have a meal at a restaurant, not simply 
because of basic human necessity for sustenance, but because the interchange fulfills a 
psychological need, which at the time has greater value than the tangible food provided 
(Blau, 1986). 
 As society developed, the need for social exchange processes to satisfy emotional 
fulfillment became greater.  So much so, desires serving only one individual without the 
involvement of another may suggest gluttony to others.  A person wishing only to eat 
alone may deprive others seeking involvement, even when the individual is satisfying 
their own desire for privacy or seclusion (Blau, 1986).  Although other examples of 
solitarily motivated activities, such as reading, watching a movie, or creating art often 
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seem withdrawn; the processes often involved future social exchanges possibilities in 
which the individual shared the experience or seeks feedback from others for emotional 
fulfillment.  Perhaps ironically, those seeking to forgo exchange processes, as defined by 
the socially implemented laws or rules, were punished by excluding them from exchange 
possibilities, such as confinement or forced procedural education (Cook & Emerson, 
1987). 
 Not surprisingly, many individuals learned to circumvent social exchange processes 
to benefit themselves, while remaining compliant with existing laws and procedures.  The 
development of exploitation through excessive obligations emerged when a person 
willingly engaged in an exchange when the other has insufficient trade.  Although the 
individual with the higher valued commodity may seem to obtain diminished return, a 
condition associated with the trade may involve future commitments, which in time 
increased the value of the original trade (Thibaut, 1986).  It is commonplace in modern 
time to accept the conditions of a financial loan, even when it exceeds the cost of that 
which is obtained.  Although this process originated from various forms of historical 
exploitation, the practice became socially accepted so as to provide increased potential 
for greater exchange possibilities (Blue, 1986).  
 So complicated have exchange processes become, individuals seeking value 
through such transactions must be willing to accept potentially negative outcomes (Ekeh, 
1974).  Historically, groups agreed to battle for dominance with the understanding their 
loss would result in defeat or even death.  However, the potential gain from such actions 
had greater value than the negative prospect.  The chance to rule or influence fulfilled 
both physical and emotional needs, and created a dominant position for increased 
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exchange possibilities.  Although evidence of these actions exists in surplus today, more 
subtle means of status differentiation and power capacity exist and flourish.  Individuals 
willingly engage in mating rituals and courtships, while understanding their needs may be 
unfulfilled or even rejected.  A man seeking the attention of a woman must compete for 
her affections and risks rejection, but the potential gain outweighs the refusal.  An 
employee who sought and obtained a promotion often does so at the expense of others, 
even when it is deserved.  A typical sporting event involves individuals or groups 
agreeing to participate in the activity even with the understanding that only one can 
prevail.  So conditioned are these social exchanges in present day that deprivation is 
accepted and even expected in most transactions (Blau, 1986). 
 Although increased social exchange processes provided greater potential for each 
member to engage in a given transaction to pacify physical or emotional needs, power 
differentiation and dominance often served to limit possibilities.  An individual ascending 
into power with the sole desire to implement their will onto others through dominance 
will seek to limit exchange possibilities among subjects to retain power and create 
dependence upon those commodities they control (Thibaut, 1986).  Perhaps ironically, 
social systems that rewarded people by increasing their influence and dominance in a 
given environment often sacrificed increased exchange potential once the individual 
obtains the power.  An employee promoted into a position of power may have obtained 
the role by acting or working differently than others and will then seek to limit the 
processes embraced by those subordinates, thereby decreasing their exchange potential. 
 Power differentiation is hardly limited to single members or groups. When social 
conditions allow freedom of alliances, large organizations develop and drive exchange 
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potential for the larger society.  Although free societies seek continuous growth for 
exchange processes, such industries may have the opposite effect.  A service organization 
developing a dominant position may seek to limit or obstruct potential competitors, often 
resulting in reduced exchange potential.  Governments ascending into power with the 
prospect of increasing social exchange possibilities may also limit others.  As social 
exchange practices seek balance among those involved, continuous processes, industries 
and governments evolve or decline when meeting these unceasing challenges. 
Literature Review 
Institutionalization of Social Exchange 
 As individuals strive to participate in exchange opportunities, they became united 
and formed groups and systems to increase the potential of interactions.  As individuals 
gravitated to others with shared values and goals, their connection expanded to form 
larger social systems (Cook & Emerson, 1987).  Blau (1986) explained how such 
motivations serve to create larger social systems:  
 Social relations unite not only individuals in groups, but also groups in 
communities and societies. The association between individuals tends to become 
organized into complex social structures, and they often become institutionalized to 
perpetuate the form of organization far beyond the life span of human beings. (p. 
13) 
 
The creation of such alliances also fulfilled the emotional needs of each member and 
generated further investment in its continuation and expansion.  Two individuals trading 
food for clothing both obtained basic necessities and could become dependent upon the 
other for vitality.  When others are permitted to add new items for exchange, the 
relationship expanded to include new possibilities for acquisition.  As each new member 
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joined, they became invested in protecting the sanctity of the arrangement and expanded 
into new areas of commerce. 
 Once again, a simple market exemplified this arrangement as one individual 
attempted to exchange their wares for other commodities in a set location.  Additional 
people opted to participate and began exchanging other wares in the same location.  Each 
person benefited from the other by attracting more clientele and increased the potential to 
exchange their products.  Once such alliances formed, the value it brings to each 
individual warranted continuous growth and protection (Blau, 1986).  Once such 
alliances became stabilized, organizations and institutions emerged.  Rules needed to 
govern the organization’s processes then formed and such procedures dictated what each 
individual may and may not do.  As the institution perpetuated, members became 
increasingly invested and the organization took greater form by expansion and 
proliferation (Blau, 1986).  Such institutions are exemplified by governmental structures, 
community organizations, and religious practices.  As society evolved, these social 
institutions formed to regulate basic needs and to stabilize necessities required for each 
member.  
 Once basic needs became balanced among participants, individualistic desires 
began to prevail.  When currency was introduced to balance exchange processes, the 
acquisition of greater resources became paramount.  Currency in of itself was not able to 
sustain life, but served as a symbolic asset and could be used to trade for any number of 
resources.  As such, institutions often served primarily economic motives to bestow 
greater wealth or currency on each participating member.  As each member accumulated 
more currency, his or her exchange investment served to perpetuate that institution.  
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While conceptually grounded in basic exchange procedures, such pursuits often led to 
imbalances within society as institutions grew to such proportions, it commanded 
exchange situations favoring only its objective at the expense of non-invested members 
(Ekeh, 1974). 
 While institutionalized groups developed values and norms to regulate goal-
oriented exchange possibilities, these processes became ingrained as operational 
procedures and served to socialize each member.  As the institution grew, it became a 
reflection of a particular society and represented their specific interests abroad (Blau, 
1986).  Social norms, business culture, and local customs were practiced when engaging 
in commerce with other societies and each exchange presented an opportunity to learn 
about the other’s culture.  Like other local cultural practices, society’s industries served 
to increase potential exchanges.  Although an institution was representative of a specific 
culture, its processes influenced others to change or create various obstacles when 
exchanges were performed without its involvement (Thibaut, 1986).  Such is the case 
when a specific group wishes to influence, integrate or dominate others. 
 Processes used to influence actions from other cultures need not be solely 
economically motivated.  Cultural, spiritual and educational motives were also embedded 
in institutionalized practices.  Cultural influences, such as entertainment, music and art 
played an important role in each specific society, and continuous developed and evolved 
to create massive industries for each facet.  Once institutionalized, these mechanisms 
were exchanged worldwide and served to influence others and transmitted cultural 
information between populations.  When other cultures experienced such influences, it 
served to impress or even manipulate their society, potentially leading to domestic 
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changes.  As these transmissions gained in influence, its value increased and became a 
commodity like any other, readily available for exchange and worthy of reciprocity 
(Cook and Emerson, 1987). 
 Traditionally, one of the most apparent forms of institutionalized exchange was that 
of religion.  Social conditions became fertile for a variety of spiritual manifestations as 
the population grew and individuals developed commonalities worthy of further 
development and exchange.  Each religion developed from social norms and common 
values, and served to stabilize provincial conditions while representing that specific 
culture. Sharing the characteristics of other institutions, religious associations sought new 
members to increase size and influence, while introducing rigidities to minimize attrition 
and prevent others from engaging in conflicting goals (Blau, 1986).  Contention 
motivated by religious division and variance are abundant throughout history and reflect 
the potential influence gained by an institution within a given culture when its exchange 
potential becomes unwillingly confined.  In some cases, the institutionalization of a 
specific religion became so dominant; it defined the very culture itself. 
 As social systems became institutionalized, opposition movements arose when 
conditions were such that social norms permit such challenges.  Blau (1986) denoted 
coalitions seeking to challenge a particular institution often evolved into separate 
institutions.  Capitalistic nations permitted an institution to grow within the confines of 
specific laws and enforced the specific population’s perceptions of fairness and rightful 
exchange practices.  As the institution grows, it generated competition, which then 
created a separate institution by its own evolution.  Inevitably, the organizations created a 
prevailing industry, which became increasingly institutionalized and served to increase 
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exchange possibilities to sustain its continued growth. Although an organization spawned 
its own competition, the prevailing partnership united competitors and each became 
invested in its continued perpetuation. 
 When institutionalized systems gained sufficient power to regulate conditions that 
facilitated its legitimacy, imbalances in exchange potential emerged.  A government 
using available resources to solidify supreme control over other social institutions 
imposed influence or directly managed its activities to assimilate its population in a 
manner it deemed appropriate.  Even in free societies, examples of these activities were 
abundant.  Educational institutions created learning paradigms which were agreed upon 
by those in power and imposed criterion for those who were socially conditioned to 
accept such instruction if they expected to advance within that society.  Religious 
associations dictated undergoing spiritual processes necessary for social acceptance.  
Industries conditioned employees with procedural training to ensure their actions 
supported corporate goals.  While these systems facilitated continuous exchange 
possibilities within a specific culture, social evolution allowed such processes to become 
institutionalized, which directly affected each member’s ability to reciprocate within that 
society (Ekeh, 1974). 
 While conformity to social norms remained a stability pillar within each society, 
some members engaged in exchanges that circumvented institutions created for such 
purposes (Blau, 1986).  Although a process became institutionalized, gained social 
acceptance, and fortified legitimate power, imbalances emerged when alternative 
processes challenged the prevailing institution.  Depending on the social conditions 
governing these imbalances, either the institution possessed sufficient influence or power 
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to suppress challenges or was subjected to prevailing laws that permitted legitimate 
alternatives (Cook & Emerson, 1987).  However, even in democratic societies, those in 
power often agreed upon laws necessary to govern such practices and were potentially 
incentivized to increase their exchange possibilities at the expense of those they served 
(Thibaut, 1986).  As a result, citizens learning those in power supported institutions that 
limited exchange potential could expel such leaders, if social conditions allowed such 
actions.  Nonetheless, individuals within each society help legitimate prevailing rule if 
they believe the advantages of doing so outweigh alternative hardship (Blau, 1986). 
Social Exchange within the Pharmaceutical Industry 
Throughout many civilizations around the world, health care operations became 
institutionalized quickly due to the innate need for each culture to care for its citizens.  
Through this evolution, the pharmaceutical industry developed and began to operate like 
many other types of businesses.  A product was developed, marketed and exchanged, 
funding operations and strategic growth for each organization.  From this perspective, the 
pharmaceutical industry occupies a similar role in each society, in that it provides 
employment, services and remuneration.  However, the procurement of raw materials, 
innovative research, operational structure, and the employment of many citizens have 
garnered little attention since the industry’s infancy in the early to mid-20th century 
(Nakayama, 2010; Schaefer, 2007; Wechsler, 2009).   
Instead, abundant research has amassed since the fledgling industry’s beginning 
regarding the outcomes of its marketing strategies and customer engagements.  The social 
exchange platform used by representatives of drug manufacturers and their customers 
differed little from tradition transactions of commodities and goods (Eichler et al., 2009; 
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Nur & Ozsahin, 2009), but accusations of disproportionate wealth accumulation and 
negative patient outcomes increasingly swayed populace opinion to believe agents of 
these organizations willfully engaged in negative exchanges (Appelbaum, 2010; Naik et 
al., 2009; Olsen & Whalen, 2009; Ritter, 2010).  Given the social exchange realities 
suggesting superfluous transactions often lead to conflict and societal unrest, regulatory 
agencies have increased oversight and scrutiny of pharmaceutical processes (Krumholz et 
al., 2009; Nur & Ozsahin, 2009; Parker, 2007; Wechsler, 2009). 
At the heart of these arguments is often the exchange relationship shared between 
drug manufacturers and their primary customer base – physicians (Christensen, 2009; 
Crigger et al., 2008; Schaefer, 2007).  Sah and Fugh-Berman (2013) described the utility 
of pharmaceutical influence over doctors as a reciprocal relationship, like any other, but 
the introduction of incentives often subjugated medical decision making, regardless of the 
subtlety altruism.  In fact, the vastness of research encompassing the pharmaceutical 
industry centered on the notion its agents provided incentives for preferred prescribing 
and created elaborate marketing schemes to facilitate continuous reciprocity (Appelbaum, 
2010, Eichler et al., 2009, Nakayama, 2010, Sah & Fugh-Berman, 2013). 
Within this spectrum of social exchange, drug manufacturers enticed physicians 
with financial inducements, deference, or stature (Crigger et al., 2008; Nur & Ozsahin, 
2009; Parker, 2007).  Whether these pursuits lead to inequity or worsening patient health 
is often a contentious philosophical debate, which continues to fuel the growing body of 
literature surrounding this topic.  Though many regulators and public service 
organizations voiced concern over proposed pharmaceutical coercion of health care 
practices, some have offered occasional notions of defense and defined situations in 
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which the two parties can coexist without untoward consequences (Appelbaum, 2010; 
Krumholz et al., 2009; Nakayama, 2010).  Within these arguments, underpinnings of 
financial support to facilitate continued operations, educational fulfillment, and the 
general will to identify new medicines culminated to form a platform of guardianship for 
drug manufacturers (Olsen & Whalen, 2009; Ritter, 2010). 
  Regardless of the intent of pharmaceutical agents, the perception of unequal 
exchanges remained ever present in society (Olsen & Whalen, 2009; Parker, 2007; Ritter, 
2010).  Though many therapeutic areas of medicine have enacted various 
recommendations for pharmaceutical industry interactions, some have had considerably 
less exposure with drug manufacturer personnel.  Cardiology, for example, enacted its 
guidance document for industry relationships in 2008 and oncology in 2013 (American 
College of Cardiology, 2008; Spence, 2013).  Rheumatology, in contrast, has only 
recently begun to explore this issue due to the increased incursion of pharmaceutical 
agents in this field.  MacKenzie, Meltzer, Kitsis and Mancuso (2013) explained the 
organization’s efforts to identify areas of potential influence through practitioner 
questionnaires, but the resulting outcomes only generalized pharmaceutical intentness.  
According to a 2013 survey, rheumatologists perceived direct financial involvement with 
a drug manufacturer, such as serving on the board of directors, as the most questionable 
ethical activity (MacKenzie et al., 2013).   
 Other areas of medicine shared the same ethical questions as rheumatologists.  
Fischer et al. (2009), Naik et al. (2009) and Nakayama (2010) explained the extent of 
ethical activity typically derived from monetary reimbursements offered by drug 
manufacturers.  Such payments came in the form of consultant fees, clinical trial conduct, 
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or meals and recreation (Appelbaum, 2010; Parker, 2007).  Though some defended these 
types of reimbursements as ethical and moralistic (Krumholz et al., 2009; Nakayama, 
2010; Ritter, 2010), MacKenzie (2013) explained these industry-related experiences 
offered important lessons for rheumatologists and their exchange networks.  As such, the 
negligible literature available for this specialty’s exchanges with pharmaceutical agents 
requires further exploration and understanding (MacKenzie et al., 2013). 
The Need For Authority 
 Whether it is an individual, community or institution engaged in exchanges with 
others, rules governing the morality of each transaction became critical when applying 
the prevailing social norms (Blau, 1986).  When individuals or institutions obtained 
sufficient power to dictate the exchange possibilities of those influenced, imbalances 
emerged and created growing instability (Ekeh, 1974).  While each society developed 
conditioned concepts of fairness and justice, such perceptions usually served the demands 
of that specific culture (Cook & Emerson, 1987).  If a militant civilization believed 
conquest is necessary to assimilate new members, then the methods used to accomplish 
such goals were justified within that society.  A society ruled by a single institutionalized 
power, such as religion, seeks to restrict exchange opportunities with other cultures so as 
not to permit potential challenges to its rule.  Those conditioned in this society believed 
such actions were just in order to retain their virtue and to ensure favor in the afterlife.  
The social norms developed over time within a given society governed exchange 
potential and resulted in specific justifications of each member’s actions (Blau, 1986).   
 Although general acceptance of authority often facilitated a specific culture’s 
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ability to engage in social exchanges, the concept of justice varied among members.  
Ekeh (1974) explains:  
There is justice in the superiority of society or more concrete groups over 
individuals who will have to consider their interests as unequal to the demands of 
the wider society. This may mean that inequalities between individuals, which 
interfere with the superiority of the total social structure, may become defined as 
unjustifiable. On the other hand, individualistic sociologists generally see individual 
attainments as evidence of ability differentials and hence see inequality as 
justifiable. (p. 145) 
 
From this perspective it is clear superiority and equality were subjective among members 
of a given society. Those seeking to challenge existing dogma believed themselves to be 
superior over others and often do so because they believe inequality exists.  Depending 
on prevailing laws and social structure, the individual was persecuted, defended or 
praised.  In either case, the opposing view challenged established social norms that 
developed over time and dictated specific actions and behaviors (Thibaut, 1986).  
Depending on how the social structure sanctioned such actions, the outcome created new 
norms or enforced existing ones. 
 Blau (1986) suggested the need for increased exchange possibilities would generate 
in-group pressures, which can lead to instability within the agreed social practices.  Such 
circumstances required authoritative actions to preserve normative standards (Ekeh, 
1974).  Violence, persuasion, intimidation and coercion developed between players as 
tactics to fulfill individual exchange motives when socially justified methods failed.  If 
prevailing social norms rewarded such actions, even when the methods used to obtain it 
were unjust, unstable conditions began to develop as others engaged in similar actions 
(Cook & Emerson, 1987).  Authority is necessary to limit such instabilities and restored 
the social order to that which was agreed upon by the dominant masses. 
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 When a civilization collectively provided power to an individual or group, they 
began to submit to it and legitimated its rule (Blau, 1986).  The legitimacy derived from 
these actions fulfilled each individual’s desire for increased social exchange potential 
under the ruling body it created.  If the ability of social exchange began to diminish, the 
legitimacy of the ruling factors became threatened and social instability ensued.  As 
society flourished and expanded, tighter social controls were necessary to preserve 
equitable exchange processes (Thibaut, 1986).  Furthermore, authoritarian bodies began 
to expand and institutionalized in order to focus on specific aspects of social controls.  
Power then began to shift from a central nexus to distinct branches, each empowered to 
control specific social functions using justified methods approved or accepted by the 
masses. 
 These evolving processes gave rise to civil governments, which applied and 
enforced social norms to facilitate continuous exchange among members. The ability to 
engage in social exchange practices was a commodity in of itself in such societies.  
Individuals allowed to engage in comprehensive exchange activities under social norms 
enforced by authoritative bodies could provide numerous advantages, which often 
compensate the burden necessary to maintain continuous compliance (Blau, 1986).  In 
fact, Blau (1986) surmised this process often resulted in obligatory actions by individuals 
within this society because they believed their system to be just and worthy of 
preservation and expansion. 
 Societies without collective authority and those tightly controlled by non-legitimate 
forces foster opposition because of the lack of social exchange evolution (Cook & 
Emerson, 1987).  Such circumstances created various imbalances because resources were 
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diverted to preserving social controls rather than benefiting the citizens suppressed under 
those conditions.  Exchange processes then created insufficient compensation for 
involved members, leading to social instability and inevitably reprisal (Blau, 1986).  
Thibaut (1986) explained legitimate rule provided advantageous exchange potential for 
social members even in the absence of compensation because compliance with prevailing 
norms increased worth over a variety of other exchange possibilities. 
 Even under stable conditions, individuals and organizations sought to increase 
exchange potential, even at the expense of others.  If social norms rewarded such actions, 
methods used to acquire materials or power were still regulated in order to comply with 
the legitimate authority imposed by the society. Democratic societies engaged in 
capitalistic pursuits allowed organizations to gain advantages over other institutions and 
consumed its resources.  In such cases, those involved often benefited from the exchange 
process.  The dominant organization provided financial compensation or allowed new 
exchange possibilities for those affected.  However, power differentiation provided by the 
social exchange required regulation because the negative impact to the larger society 
created instabilities.  Nevertheless, those whose exchange potential was reduced deemed 
some exchanges allowed under democratic rule unjust.  A company buying another 
company did so using legitimate means, but those left without a job experienced negative 
outcomes.  The legitimacy of such exchanges was socially justifiable because those in 
power or those representing the larger majority obtained their desired exchange outcome. 
Prevailing social norms regulated by legitimate power justified a variety of actions 
by individuals and organizations, as each became more dependent upon the other.  
Consensus and equality emerged from societal interdependence, both from individual and 
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organizational perspectives (Ekeh, 1974).  A person within such a civilization gained 
equality among others when legitimate rule facilitated equitable exchange opportunities.  
An organization adhering to practices deemed appropriate by social consensus increased 
its investment within society because exchanges benefited those who represented the 
organization (Ekeh, 1974).  As social investment by each member increased, a sense of 
citizenship developed and permitted greater opportunities to contribute to the larger 
societal unison. 
 Authoritarian structures facilitating increased social exchange possibilities obtained 
power by those submitting to it because of the rewards it provided (Cook & Emerson, 
1987).  Illegitimate forces striving to obtain power and status differentiation likely 
resorted to coercive practices, creating inequities and instability (Ekeh, 1974). 
Sustainable governments enforced and maintained social norms created by prevailing 
consensus among its citizens.  Thus, the necessity of this rule was to preserve authority 
and maintain equitable exchange practices among its members.  Individuals refusing to 
submit to the laws created by a legitimate authority risked persecution or restriction of 
their social exchange potential (Thibaut, 1986).  Although the goal of legitimate authority 
was to preserve social norms, threats from other civilizations whose exchange goals 
created conflicts altered societal priorities and shifted exchange practices (Cook & 
Emerson, 1987).  
 Because each individual was dependent upon the other to mount a significant 
defense against the threat, exchange practices were altered to achieve new priorities 
(Ekeh, 1974).  The common recognition of the challenge strengthened relationships 
between invested members and increased social exchange opportunities.  The strength of 
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each opponent was derived upon the preceding series of exchanges within that social 
setting and coalesced into a more powerful force (Cook & Emerson, 1987).  The outcome 
of the conflict then modified the exchange possibilities within the new culture.  The 
victor obtained new resources and increased its interdependence on its growing social 
structure (Cook & Emerson, 1987). 
Social Exchange in the Modern Era 
 When synthesizing the various types of alliances and partnerships seen in today’s 
social environment, several viewpoints emerged.  First, institutionalization has increased 
dramatically over the decades, leaving many citizens increasingly dependent on their 
socially derived services (Luo, 2007).  Individual employment, consumption and vitality 
became ever linked to the social institutions derived through social exchange mechanisms 
and fulfilled the needs of each citizen (Lawler, Thye, & Yoon, 2008).  Within this 
environment, individuals and vast social conglomerates engaged in a variety of exchange 
processes on a daily basis.  Because of the interdependence citizens and their social 
institutions were shared, each was invested in expanding social exchange opportunities 
for the other (Blau, 1986).  Hence, if the cultural organizations created to increase 
exchange possibilities failed, then the citizens relying on the institution suffered. 
 Societal institutions accomplished exchange mechanisms with greater efficiency 
and benefited when alliances were created to facilitate a more trusting environment 
(Molm, Collett, & Schaefer, 2006).  Such short-term inter-organizational alliances were 
common when corporate mandates dictated the implementation of a new process or any 
activity aimed at a specific objective.  Bignoux (2006) explained the social exchange 
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motivation within these groups hinged on the motivation of each participant to help the 
other achieve a common goal.  This was the case when reviewing the short-term alliance 
parameters between physicians and the pharmaceutical industry.   The syndicates 
involved work closely together for a specific timeframe and achieved a common goal, 
previously unattainable by each alone (Bignoux, 2006).  However, conflict and coercion 
developed in such relationships, partly because of the failure to fully depend on a partner, 
and also because of lack of trust (Fehr & Gintis, 2007).  Hence, the impetus of reward 
versus cost in formed relationships motivated both individual and organizational choice. 
 While many business relationships formed through aspects of social exchange, the 
transaction of knowledge became increasingly common and important (Chen & Choi, 
2005).  The advent of information technology has facilitated greater exchanges while 
introducing new ethical dilemmas for traditional social exchange processes.  Monetary 
transactions often resulted from business exchange practices as the increasing importance 
of knowledge acquisition required new ethical mindsets for exchange participants (Chen 
& Choi, 2005).  As Blau (1986), Cook and Emerson (1987), Ekeh (1974), and Thibaut 
(1986) explained, social exchange that resulted in disparate transactions often lead to 
conflict or distrust.  Therefore, the perceived simplicity of information exchange was no 
different from other forms of social interchange.  
 Essentially, ethical applications influencing such information exchange were based 
on value domains developed through various individual and organizational behaviors 
(Chen & Choi, 2005).  These value domains were not always monetarily influenced, 
which suggested most situations involving knowledge exchange stemmed from relative 
value, such as understanding a new process to increase efficiency or gain industry-related 
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advantages (Johar, 2005).  In fact, as the limits, scope and boundaries were defined for 
knowledge exchange commitments, the transaction became ethical as each participant 
delineated the pros and cons prior to commitment (Chen & Choi, 2005). Because such 
transactions were often relative as opposed to absolute, the social exchange value for the 
knowledge gained or exchanged differed greatly among participates.  Modern business 
ethics ensured each party abided by time proven social exchange principles in order to 
avoid conflict and to facilitate a culture encouraging future exchanges (Muthusamy, 
White & Carr, 2007). 
 Exhaustive sociological experimentation performed previously suggested most 
social exchange processes were exclusively self-regarding, or conducted with the purpose 
of fulfilling individualist needs and desires (Fehr & Gintis, 2007).  However, the growing 
body of evidence from recent sociological and behavioral research provided evidence 
supporting individualistic need for reciprocal processes and engagement in 
disproportionate transactions simply to fulfill their needs.  So conditioned are modern 
civilizations to conform to prevailing norms, individual values seldom conflicted with the 
larger majority (Fehr & Gintis, 2007).  In fact, current examples of this inordinate 
behavior abound when observing reciprocal behaviors of collaborators engaged in 
charitable activities and the punishment of violators, even when said discipline involved 
costs for the victim. 
 Johar (2005) analyzed modern relationship constructs and determined many unions 
lack economic provocation because the actual association is considered more valuable.  
Through numerous recent psychological analyses, it was determined exchange partners 
were continuously trying to understand and predict the other’s behaviors (Johar, 2005).  
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Curiosity increased when unexpected actions developed within these relationships and 
were the result of a member or organization disregarding a particular social norm or 
failure to conform to the understood rules of engagement (Thibaut, 1986).  Although the 
motivation for such a violation need not be deleterious, illegal or mischievous, its 
manifestation either enriched or endangered a relationship with another (Johar, 2005). As 
Thibaut (1986) explained, social norms regulating relationship orientation among 
individuals only served as an induction, because each affiliation conceives new 
possibilities for that society and fueled societal norm development. 
 Scenario-based relationships underpinning this orientation can again be reviewed 
through the analysis of physician and drug manufacturer relationships.  Each entered into 
a collaboration in which one partner has expectations of the other.  As the relationship 
matured, trust is established when each party fulfilled a given need of the other.  
However, each individual placed different subjective and absolute values for potential 
trades, and therefore, the social norms governing the integrity of the exchange lead to 
satisfaction, coercion or violation (Johar, 2005). The repercussions of each exchange 
fueled more transactions and increased the value of the relationship. Over time, the value 
associated with the relationship influenced exchanges within each party and formulated 
overarching norms, which in turn began to govern each transaction.  The profit motive 
then matured from simple monetary or information exchange into a valued relationship, 
worthy of protection and preservation (Blau, 1986).  
 Unfortunately, profit motives were often at the root of predatory practices used both 
by individuals and organizations.  Luo and Donthu (2007) reviewed the concept of 
international opportunism as one force taking advantage of another when circumstances 
 
48 
favored corporate objectives, regardless of the outcome of the other party.  Rather than 
seeking lasting relationships through social exchange processes, some institutions opted 
to capitalize on the misfortune of another or actively employed rapacious practices to 
achieve corporate goals (Luo & Donthu, 2007).  In doing so, collaborative, partnering, 
and judicial outcomes became unattainable.  Perhaps surprisingly, individualistic 
societies actually promoted such activities as a normal business practice because 
prevailing social norms favored profit over other types of relationships.  Luo (2007) 
experimented in cross-cultural relationships and revealed those with individualistic 
tendencies were more like to engage in opportunistic exchange. 
Summary and Conclusions 
Summary 
 Each citizen within a social matrix required exchanges with others to form bonds, 
communities, organizations and cultures.  Many sought like-minded others to create 
friendships who shared common interests and similar characteristics.  Blau (1986) 
rationalized this development as a process of reciprocal incentives created through 
various exchanges, resulting in growing interdependence between the individuals in the 
relationship. Such relationships were also bound within existing social constraints, which 
dictated the societal norms necessary for conformity (Blau, 1986).  Through historical 
and current analyses, each society evolved social exchange mechanisms in a manner 
consistent within the cultural norms represented within that particular population. 
 Cook and Emerson (1987) justified these exchange processes through value theory 
of distribution in which each person sought rewards from an exchange and the morality 
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of the means to obtain it was socially derived.  The rewards obtained through an 
exchange resulted in profit for one and loss for another.  As each individual sought 
exchange potential with others, coalitions formed in an attempt to balance the exchange 
process (Ekeh, 1974; Molm et al., 2006).  When this process occurred early within a 
growing social matrix, it created collaborative societal norms and characteristics shared 
by each citizen. As the society evolved, it created laws and policies to ensure norm 
compliance and penalties for noncompliant activities (Cook & Emerson, 1987).  
Importantly, the exchange parameters governing a specific landscape of exchange were 
often dramatically different from one culture to the next, potentially resulting in 
perceived predatory behavior and eventually conflict (Luo, 2007). 
 When individual objectives clashed with prevailing social norms, a person or 
institution sought exchange opportunities with others who shared such objectives.  This 
lead to new coalitions or organizations that will grow or conflict with established social 
dogma.  If the conflict cannot be balanced within the system of available social 
exchanges, it will either escalate potential conflict or face dissolution (Fehr & Gintis, 
2007; Thibaut, 1986).  Although the aberration of the individuals involved in the conflict 
created exchange obstacles, both groups remained interdependent.  Each strived for 
commonality with the other, but faced dissolution often resulting in various forms of 
conflict (Ekeh, 1974; Siegrist, 2006).  As these conflicts resolved, new social norms were 
created or modified to include the new members in order to reach an amicable balance.  
In fact, the very nature of the contention between the competitors provided an educational 
foundation for each society to tolerate and indoctrinate new members (Cook, 1987; 
Kuwabara, Willer, Macy, Mashima, & Yamagishi, 2007).  Many cultures became defined 
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by their ability to indoctrinate new members or prevented assimilation when conflict 
arose regarding their ability to participate in social exchange (Johar, 2005) 
 As individuals navigated the complexities of do’s and don’ts allowable within their 
social arena, they learned the subtle methods to obtain desires and necessities alike.  Each 
exchange opportunity presented risk/benefit potential and the uncertainty of each 
situation provided valuable lessons (Cook & Emerson, 1987, Lawler et al., 2008).  Each 
person navigated complex exchange processes to fulfill innate aspirations developed 
throughout life.  As something new increased in value, members became willing to 
sacrifice other possessions, potentially having great personal value, to obtain it (Ekeh, 
1974; Schaefer, 2007).  When examining the relationship between physician and drug 
manufacturer, this process may unfold when the organization had a new treatment that is 
financially important for corporate goals, but the doctors saw little relative value for their 
patients.  Because the value of the product is important for the pharmaceutical 
organization, it was often willing to compensate the physician in creative ways for using 
the product.  In doing so, the value of the commodity became increased for the physicians 
if their value domains placed greater relevance on the acquisition of wealth. 
 Even within a social system dominated by power status and profit, the exchange 
rewards continuously changed to fuel further interchange (Bignoux, 2006; Muthusamy et 
al., 2007).  The individual seeking power or status did so by identifying and engaging in 
exchanges promoting such actions, while at the same time sacrificing other actions.  The 
individual placing higher value on actions unrelated to power acquisition alleviated this 
need by fulfilling that which they felt was more crucial.  A person climbing the social 
latter may forgo friendships, family or integrity to obtain it, whereas another individual 
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may place little to no value on this compared to simply sustaining their relationships.  
Nonetheless, both parties within this social condition relied on each other to provide the 
necessary opportunities to fulfill their individual needs (Blau, 1986). 
 As a consequence of this interdependence, the social appetite for new exchange 
potential became apparent.  When exchange possibilities diminished, each collaborator 
became more reliant on remaining members to fulfill their needs and desires (Lawler et 
al., 2008; Molm, Schaefer & Collett, 2007).  When social unrest burgeoned from lack of 
exchange potential, it fueled any number of actions to replenish civilian magnitude.  
Human history contained abundant examples of conflicts and campaigns fueled by social 
unrest to obtain new members, land or resources.  Each of these commodities represented 
further exchange potential for the assailants.  Conflict is still readily evident today, as 
resources become limited and societal appetites for continuous growth and exchanges 
progressively increase.  Social interdependence is now transcending borders, nationalities 
and cultural stigmas, and further binding each individual to the other to precipitate 
continuous exchange. 
Conclusion 
Social Exchange Theory encompasses the parameters and conditions regarding 
the interchange between multiple parties (Thibaut, 1986).  Both rheumatologists and the 
pharmaceutical industry represent unique stakeholders in the application of health care 
within a given population.  Because of this shared pursuit, both engaged in various 
exchanges over time.  However, the provision of medical care for an entire society 
required many different exchange partners and collaborators (Siegrist, 2006).  Blau 
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(1986) describes how the many facets of an institutionalized process created unique 
groups, each with its own objectives, philosophical desires, and mechanisms for 
achieving its goals.  Through the complexities of social exchange processes, each party 
employed any number of mechanisms to influence the other (Chen & Choi, 2005; Luo, 
2007). 
 Because social interchange between members required boundaries and regulations 
to justify exchange processes, the prevailing social norms presented during a given 
transaction became the ethical compass by which to judge its perceived morality (Luo, 
2007).  Although physicians apply care directly to patients, the provisions of equitable 
exchange may be different than that of an institutionalized group not having direct 
contact with patients.  Furthermore, a capitalistic society placing high value on monetary 
returns may apply a uniquely different equitable lens when evaluating exchanges made 
with its interchange partners (Schaefer, 2007).  Though the actual morality of each 
exchange between these partners remained subjective depending on the value domains 
each individual applied, the fact remained each was an important collaborator in the 
fulfillment of medical care. 
 Social exchange theory seeks to achieve and maintain balance within a given 
societal matrix, but each philosopher examined the common use of coercion and self-gain 
to achieve his or her means (Blau, 1986; Cook & Emerson, 1987; Ekeh, 1974; Thibaut, 
1986).  Such mechanisms to apply influence on an exchange partner exist in many cases 
of social interchange.  However, the use of unscrupulous means to achieve one’s goals 
often leads to imbalances and conflict (Chen & Choi, 2005).  Because such actions 
required repetition and time in order to swell into a larger cultural deviation, the 
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subtleties of perceived influence often went unnoticed (Molm et al., 2007).  Because trust 
increased over time between social exchange partners, the untoward influence each 
applied to the other to achieve their goals usually fulfilled their individual desires 
(Schaefer, 2007).  It is when such pursuits resulted in large-scale imbalances that 
instability arose and dictated balancing forces to intervene (Cook & Emerson, 1987).   
 As previously examined, social exchange required partnerships, balance, trust and 
regulation.  Each parameter exists within physician and pharmaceutical industry 
exchanges.  Though each party represented a distinct group, each must balance its own 
in-group pressures and expectations when dealing with interchange partners (Bignoux, 
2006).  This was further necessary when both exchange collaborators depend greatly on 
the other to continuously operate and fulfill the social role designation it was intended for 
(Fehr & Gintis, 2007).  Although social exchange lead to justification of a process or 
outcome, even when the outcomes were harmful to both groups, the provisions of the 
exchange occurred within a social circumstance that allowed it to occur (Muthusamy et 
al., 2007).   
The United States health care system operates in a free market, with many 
individuals and institutions incorporating for-profit business models.  Regardless of 
existing social dogma permitting physicians and drug manufacturers to engage in 
exchanges, the resulting outcomes should not result in societal imbalances elsewhere.  
Understanding and interpreting the influence one exchange partner has over the other 
may elucidate underlying motives and outcomes warranting further evaluation or scrutiny.  
Given the fact no evidence exists regarding the influence pharmaceutical organizations 
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may have on rheumatologist’s application of patient care, this proposed inquiry could 
provide valuable insights regarding both positive and negative exchange processes. 
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Chapter 3: Methodology 
 The purpose of this study was to understand the pharmaceutical industry’s effects 
on rheumatologists’ patterns of patient care.  This information reflects the lived 
experiences of participating rheumatologists and their interpretation of their experiences 
with drug manufacturers.  Given the breadth of potential individual perceptions, a 
qualitative study design was amenable to explore the lived experiences of study 
participants.  In this chapter, I describe the phenomenological research approach and 
characteristics related to its appropriate application.  In addition, I examine the 
methodological specifics of the research, including study setting, development and use of 
the instrumentation, subject selection, verifiability and generalizability properties, ethical 
considerations, and the procedure informing the data analysis of results. 
Research Design and Rationale 
In this study, I examined the lived experiences of rheumatologists and the effect 
that the pharmaceutical industry had on their patterns of patient care.  Through this 
qualitative phenomenological study, I gained insights regarding how drug makers 
influenced rheumatologists and how this influence has impacted the care provided for 
their patients.  Creswell (2007) explained that qualitative researchers seek to understand 
the meaning individuals ascribe to a given situation or circumstance.  In doing so, the 
researcher may consider five unique approaches to engage in qualitative research: 
narrative, phenomenological, ground theory, ethnography, and case study.  Though each 
of these approaches employs congruent data collection methods to explore individual 
experiences, each approach is distinguished by differing units of analysis, data gathering 
tools, and data analysis strategies.   
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 In order to apply the proper research design to address the research question that 
guided my research, each qualitative methodology was considered.  Creswell (2007) 
explained that narrative researchers explore life’s experiences through story telling.  Once 
a study participant’s stories are analyzed, the information is generalized in the form of a 
new story through the linkage of new ideas (Creswell, 2007).  Similar to narrative 
approaches, phenomenological scholars seek to understand the essence of shared 
experiences in a small group of individuals.  The description of a given phenomenon then 
allows the researcher to examine the “how” and “what” of the shared experience 
(Creswell, 2007).  In contrast, grounded theorists seek to elucidate a theory of a given 
process, which may then provide a conceptual framework for the topic being studied 
(Creswell, 2007).  This approach is often employed in the absence of an existing theory, 
which may provide the necessary context for the situation under evaluation.   
When examining larger populations to understand a cultural-level circumstance, 
ethnography may be a more appropriate choice of research design.  In this design the 
researcher becomes immersed in the daily lives of the study group and examines cultural 
themes (Creswell, 2007).  Lastly, in a case study, the researcher seeks to analyze the in-
depth meaning of a given case within a “bounded” system (Creswell, 2007).  This 
approach is well suited to gain deep insights regarding a given situation with specific 
characteristics that limit its application to other cases (i.e., bound). 
 A phenomenological study design was selected for this research to elucidate the 
lived experiences of rheumatologists regarding the potential influence the pharmaceutical 
industry has on their patterns of patient care.  I aimed to determine “what” these 
influences are and “how” such experiences have impacted their patient care.  As such, the 
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focus on the essence of these lived experiences distinguished it from other qualitative 
research approaches.  Also, the intent of this examination was to learn from multiple 
subjects’ experiences, abrogating it from a narrative research approach.  Furthermore, the 
theoretical framework of social exchange theory provides the necessary conceptual 
context for study.  In a grounded theory design, a researcher would seek to identify a new 
sociological theory in order to interpret these experiences; this design is, therefore, not an 
appropriate research scheme.   
The target study population is a rather homogeneous population of 
rheumatologists, consisting of board-certified physicians in the field of rheumatology in 
the states of Alabama, Florida, Georgia, and Mississippi.  Ethnological researchers seek 
to interpret cultural-level characteristics, which is not necessarily translatable to the 
pursuit of this research (Creswell, 2007).  Lastly, I sought to examine a phenomenon 
rather than a single bounded case.  Because case study research would require specific 
boundaries to be in place, the research topic presented in this study may not become 
generalizable with this approach (Creswell, 2007). 
The use of qualitative research has increased over the years (Bellenger, Bernhardt, 
& Goldstucker, 2011; Bluhm, Harman, & Lee, 2011; Cassell & Symon, 2011; Lacey, 
2009); throughout the spectrum of industries and social role disciplines, so it is not 
surprising that the uptake of this methodology has increased in the health care arenas as 
well (Leeman & Sandelowski, 2012; Morse, 2012; Speziale, Streubert, & Carpenter, 
2011).  The traditional use of quantitative research in drug trials became the philosophical 
lynchpin for the pharmaceutical industry for decades in order to prove the effectiveness 
of new treatments (Gallin & Ognibene, 2012).  However, many drug manufacturers are 
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learning the value of customer and patient feedback mechanisms, which serve to inform 
further research and ensure a greater body of evidence for registration purposes with 
health ministries around the world (Gallin & Ognibene, 2012).   
Within the qualitative research disciplines exists a plethora of philosophical, 
procedural, and methodological opportunities (Patton, 2002).  Though the approaches for 
qualitative inquiry may seem diverse, several fundamental attributes are shared among 
each research method.  Qualitative researchers often seek to describe, decrypt, translate, 
and determine the meaning of a given case or phenomenon (Creswell, 2007).  In contrast, 
quantitative approaches are often used to determine the frequency of a given 
circumstance or event (Patton, 2002).  Though enumerating a specific event within an 
artificial clinical trial environment may elucidate a pattern of improvement or 
deterioration, it often fails to capture other pertinent information that translates to 
individual patient experiences (Al-Busaidi, 2008).   
Describing the essence and meaning of a phenomenon should not rely on 
deductive experimentation, but rather observation and active participation by the 
researcher (Creswell, 2007).  Phenomenological researchers promote both descriptive and 
interpretive processes, but require the comprehension of various philosophical 
assumptions (Creswell, 2007).  According to the framework of social exchange theory 
individuals are linked together in a social matrix and are connected through the sharing of 
real world experiences by continuous interchange (Thibaut, 1986).  The exploration of 
these real experiences provides the phenomena and drove the goal of this particular 
research. 
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Role of the Researcher 
 Creswell (2007) and Patton (2002) explained that the researcher is the primary 
instrument for data capture in qualitative studies.  Throughout this process, the researcher 
examines documentation and behaviors and directly interacts with study participants 
(Creswell, 2007).  In phenomenological research, commonalities between study 
participants are identified and then synthesized to form a description related to their 
shared experience (Wertz et al., 2011).  As such, the researcher engages in actions, such 
as interviewing and observations, as the primary methodologies of information gathering.  
In contrast, quantitative researchers use reliability as a source of verification, whereas 
phenomenologists employ validity (Patton, 2002).  Though both approaches to research 
have various strengths and weaknesses, each is often seen as complementary to the other 
and can aid in the understanding of a given event. 
 An important component of any research is the methodology used to guide its 
conduct.  Wertz et al. (2011) examined existing arguments for research investigation and 
to determine which of the study methods is appropriate for a given investigation, but 
Creswell (2007) explained that the best research approach is one that effectively and 
efficiently addresses the research question(s).  From this perspective, qualitative analyses 
take form as researchers seek to understand the meaning of a given event, rather than 
simply quantifying a specific variable and then juxtaposing its rate of frequency with a 
specific explanation.  Rather, phenomenological pursuits begin with exploring the beliefs 
and understanding that serve to influence a given reaction or behavior (Wertz et al., 2011).  
These lived experiences bring to light individual presuppositions and assumptions 
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regarding the research topic, which can then serve to inform additional research regarding 
a given topic. 
 The inductive process of phenomenological research was previously criticized in 
health care research due to its separation of theory and method, but additional use and 
exploration of this approach has proven to enrich existing bodies of medical knowledge 
(Speziale et al., 2011).  Too often, quantitative researchers failed to elucidate the purpose 
or meaning of a given result and sought to extrapolate other reasoning for a particular 
outcome (Lacey, 2009).  As a result, qualitative analysis has emerged as an instrument to 
provide new insights on treatment decision making and deductive processes that provide 
the theoretical framework for a given pathway (Bluhm et al., 2011).  Understanding the 
commonalities of these processes can then serve to create better educational opportunities 
for information sharing, thereby improving patient outcomes and increasing shared 
understanding between practitioners. 
 In the present study, I acted as the observer and participant (Creswell, 2007).  
However, in order for the findings to have credibility, adherence to rigorous 
methodological approaches and scholarly integrity is necessary when designing, 
implementing and analyzing the findings (Patton, 2002).  Because I professionally 
resided in the therapeutic discipline of rheumatology and worked directly with 
rheumatologists, reflection and bracketing were necessary to ensure that my personal 
predilections and assumptions do not interfere with data analysis (Gearing, 2004).  The 
employment of bracketing for this study required me to distance myself from current or 
previous beliefs in order to alleviate bias or preconceived assumptions regarding the 
phenomenon under investigation (Gearing, 2004).  Creswell (2007) and Patton (2002) 
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explained that relinquishing of all possible predictions and beliefs is not feasible given 
the fact because the researcher plays an active role in the study. 
 The study participants and I sought to elucidate the effects of the pharmaceutical 
industry on rheumatologists’ pattern of patient care.  Through the construction of this 
phenomenon, I set aside prior experiences with each study participant and explored this 
topic from a open-minded manner in order to ascertain impartial and unbiased findings.  
In doing so, I rescinded prior knowledge and expectations during the data gathering 
process.  Furthermore, bracketing helped me to inform the research and interview 
questions for this research.  Creswell (2007), Patton (2002), and Wertz (2005) claimed 
that the researcher’s prior knowledge of the investigation undertaken is not necessarily 
impairing, but rather remains as a passive awareness, which does not influence or 
interfere with participant responses. 
 Additional ethical considerations for this study were environmental.  Because 
interviews were conducted within the rheumatologists’ practices, time, background 
interferences, and individual promptness may differ between each study participant.  If a 
rheumatologist is running late or has an increased patient load on the day of the interview, 
their experiences regarding the effects of the pharmaceutical industry may be influenced 
by the fact that a representative from a drug manufacturer is conflicting with his or her 
practice commitments.  In order to reduce potential for this occurrence, I sought to 
conduct interviews in the early AM or late PM to avoid the rheumatologists’ obligations 
to their patients.  Lastly, some study participants may have had concerns regarding their 
business relationship with me if they expressed negative connotations regarding the 
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individual’s employer.  To alleviate this predilection, I ensured that the participants 
understood my neutrality and the impartial nature of this inquiry. 
Methodology 
Participant Selection Logic 
Approximately 5,000 rheumatologists practice in the United States (Deal et al., 
2007).  Maxwell (2005) explained that sample size considerations in qualitative research 
must include the proposed methodological approach, study purpose, and the proposed 
research questions.  Creswell (2007) and Patton (2002) both explained that such sample 
determinations should also include the phenomenon of the research, and the researcher 
must obtain enough study participants to adequately address the research question 
guiding the investigation.  According to Creswell (2007) and Maxwell (2005), 
phenomenological research typically includes approximately five-25 subjects.  The 
enumeration should allow the researcher ample information to understand and describe 
the general lived experiences of the research participants regarding the study topic.   
 In order to select an appropriate subject number for this investigation, I 
considered sampling strategies from both quantitative and qualitative research methods.   
Goertz and Mahoney (2012) expounded on the contrasting approach in quantitative 
research in which greater numbers of study participants increase the statistical power and 
provide the necessary link between the empirical observation and the mathematical 
measurement for hypothesis formation.  In basic terms, both approaches seek to learn 
more about a given topic, but the questions proposed in quantitative research are often 
narrow, whereas qualitative inquiries tend to be broader (Creswell, 2007; Goertz & 
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Mahoney, 2012; Patton, 2002).  When considering the number of subjects to include in 
this study, I sought to obtain sufficient study participants to assure that the perceptions 
and lived experiences obtained reflect the larger rheumatology community.   
 In order to achieve this goal, saturation was used as a guiding principle regarding 
study sample size.  Mason (2010) described the concept of saturation as a process 
obtaining all or most of the available information of interest without being overly 
repetitive or superfluous.  Application of this concept in the present study required me to 
consider the various environments and practice types encompassing the U.S. 
rheumatology community.  At present, rheumatologists can be divided into two specific 
subgroups: private practice or academic appointment.  Though practitioners may operate 
in single or group environments in either private or academic settings, the two primary 
subgroups remain essentially homogeneous.   
 Rheumatologists in private settings meet with various pharmaceutical 
representatives and engage in varied discourse, including marketing interactions, clinical 
trial data review, and scientific exchange.  Academic rheumatologists may have similar 
interactions with pharmaceutical personnel, but may also seek funding for unrestricted 
education and/or research grants.  In either case, drug manufacturers act as health care 
matrix team members by providing educational sustenance, in various forms, for each 
practitioner.  In addition to this educational discourse, marketing messaging and 
consultancy agreements exist within varied formats for each region of the country. 
 Although rheumatology practice methods vary little from state to state (American 
College of Rheumatology, 2012), the managed care and political environment may 
introduce some regional differences between study participants (Crigger et al., 2008).  As 
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such, subject selection encompassed more than one state in order to reduce this 
environmental affect.  I planned to interview rheumatologists in the states of Alabama, 
Florida, Georgia, and Mississippi in order to obtain sufficient saturation data regarding 
the effects drug manufacturers have had on the care they provide to their patients.   
 Given the in-depth immersive element associated with this phenomenological 
pursuit, 10 rheumatologists were interviewed to obtain the essence of their experiences 
regarding the effects drug manufacturers have had on their application of care for patients.  
Though the variation of experiences regarding collaboration between pharmaceutical 
representatives and rheumatologists may result in a deluge of information, potentially 
suggesting saturation would require a large number of subjects, the philosophical 
framework of social exchange narrows this research pursuit.  Morse (2000) explained that 
the richness of the data obtained relates directly to the research question(s) and dictates 
the number of selected participants.  The in-depth interview process associated with this 
research was used to capture the abundance of each participant’s experience with the 
pharmaceutical industry.  This immersive element provided the necessary saturation with 
the purposely selected study participants. 
Instrumentation 
I selected the interview process for this inquiry because of the flexibility it 
provides for both the investigator and the study subjects.  The direct information 
exchange process facilitated by this system allows each participant the opportunity to 
recall events and personal situations pertinent to this research topic (Maxwell, 2005).  In 
addition, the investigator has an opportunity to clarify information or subject responses to 
fully understand the breadth and depth of each response.  Additionally, the qualitative 
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nature of this process allowed me the opportunity to use standard prompts so each 
participant could freely provide his or her personal perspective.  The questions asked in 
this research served to elucidate the effect drug manufacturers have had on 
rheumatologist’s patient care.   
 In order to ensure the conduct of the interview process accurately fulfilled the 
needs of my research, different formats and approaches were considered.  Creswell 
(2007), Maxwell (2005), Morse (2012), Patton (2002), and Wertz et al. (2005) explained 
that the two most common types of interviews used in phenomenological research are 
structured and semistructured.  Additional categorization may also frame the interview 
process as open-ended or close-ended, depending on the research questions and the study 
methodology (Creswell, 2007).  Although a variety of interview protocols may be 
employed when obtaining qualitative data, I concluded that Rubin and Rubin’s (2005) 
responsive model would be appropriate for this study.  This approach consists of an 
introduction to the study under investigation, open-ended interview questions, and an 
informal interaction method to facilitate openness.  The use of standardized prompts may 
also facilitate the conversation and discussion so as to elucidate the breadth and depth of 
the research topic (Rubin & Rubin, 2005).   
 Larkin, Watts and Clifton (2006) explained the above interpretive process 
encompassed the realization from both the participant and I that the knowledge and 
experience of both parties allowed me to develop and detail an understanding of the 
phenomenon under investigation.  Additionally, the informal nature of the interview 
engagement process allowed each subject to engage me in a manner facilitating an open 
and honest dialog (Patton, 2002).  As such, study participants described the importance of 
 
66 
their lived experiences by explaining the meaning it had for them, which allowed me to 
detail these events and processes in order to extrapolate the underlying themes (Creswell, 
2007).  The implementation of Rubin and Rubin’s (2005) model for this research 
consisted of an open-ended interview process in which the dialog was audio taped and 
later transcribed.  As per Creswell (2007) and Patton’s (2002) guidance, the information 
captured after each interview was quickly transcribed so as to convey accurate 
information and undertones associated with each interaction. 
Prior to soliciting study subjects, written approval from the Walden University 
Institutional Review Board (IRB) was obtained.  Each subject was invited to participate 
in this research via direct interaction, telephone or email.  The invitation script is 
presented in Appendix A.  In addition, consent (Appendix B) to participant in this study 
was obtained for each research participant prior to the interview process.  The instrument 
used in this research was a researcher-designed interview protocol (Appendix C) based 
on the theoretical framework presented in Chapter 1.  The validity of the interview 
protocol was established in a pilot program in which the researcher obtained feedback 
from two rheumatologists regarding the effects pharmaceutical exposure has had on the 
care they provided to their patients.  The feedback obtained from the rheumatologists 
participating in the pilot interviews informed the final interview protocol. 
Pilot Study 
The pilot interview process included two rheumatologists as expert reviewers to 
assess the understandability of the questions.  Once the determination of whether the 
interview questions accurately addressed the research question for this inquiry, the larger 
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study group was solicited for interviews.  The same open-ended format previously 
described was employed during this process to allow undirected feedback.  The inclusion 
process for subject selection of the pilot and larger study included rheumatologists, either 
in private practice or academic settings.  The purpose of the pilot study was to determine 
if the interview process facilitated the necessary dialog to answer the research questions.  
The insights obtained through this mechanism served to confirm current interview 
protocol. 
 Following the pilot study, ten rheumatologists were interviewed in the Southeast 
region of the United States.  The researcher conducted each interview, audiotaped each 
event, and transcribed the information shortly thereafter.  The frequency of the data 
collection and interview process was dictated by my ability to obtain appointments from 
each study participant.  The resulting study enrollment and interview period consisted of 
three months.  Once consent and scheduled interactions were obtained, the investigator 
used the recording mechanism from a mobile device to capture subject feedback.  In the 
consenting process, each subject was made aware of the purpose of the study, the 
expected duration of the interview (approximately 30-60 minutes each), and the 
debriefing process to allow me the opportunity to summarize the information exchanged 
(Creswell, 2007; Maxwell, 2005).  Lastly, each participant received thanks for their 
participation at the conclusion of each interview. 
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Procedures for Recruitment, Participation, and Data Collection 
Recruitment 
I interviewed rheumatologists in the states of Alabama, Florida and Georgia to 
obtain sufficient saturation data regarding the effects drug manufacturers have had on the 
care they provided to their patients.  Each potential subject was approached either by 
email, telephone or direct interaction.  I contacted each subject myself and without the 
assistance or involvement of others or a third party.  Engagement frequency encompassed 
an initial interaction to assess participation interest and an additional visit to complete the 
study interview protocol for three of the protocol subjects.  The remaining subjects had 
only a single visit in which they agreed to participate and the interview was completed 
during that same visit. 
The average duration of the interviews was approximately 30 minutes, with one 
occasion lasting nearly one hour.  At the end of each session, I provided a brief summary 
of the participant’s feedback to ensure all of the pertinent points were sufficiently 
captured.  I expressed appreciation for their time and responses, and no follow-up 
sessions were required for any subject.  All interviews were recorded using my mobile 
device and additional notes were taken during each engagement.  All recordings and 
notes were further transcribed onto worded documents for data analysis.  Each document 
was compared against the original recordings and notes two times to ensure all data was 
captured and that no transcription errors occurred.  I achieved study recruitment within 
the states of Alabama, Florida and Georgia, and prior to the opportunity to solicit 
participation in Mississippi. 
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Data Analysis 
 Each interview was audio taped and later transcribed into a worded document.  
Each transcribed document was saved onto a secure computer file, which is password 
protected.  Only I will have access to the password-protected files.  Each worded 
transcript was coded and categorized by me to identify the narrative elements serving as 
specific data points (Creswell, 2007; Wertz et al., 2011).  Each transcribed document was 
thoroughly reviewed using this coding process to elucidate overarching themes.  The 
holistic process of this document review allowed me to develop a sense of each subject’s 
lived experiences regarding the research topic.  Maxwell (2005) explains this approach 
will afford me the opportunity to identify key elements of specific meanings, such as 
phrases, individual experiences, and external influences, which informed their individual 
decision making.   
 For my research, the Moustakas (1994) concept of horizonalization was employed 
for data analysis.  Within this approach, significant statements made by the research 
participants were highlighted and served to provide meaning and understanding for their 
experiences related to the research question (Creswell, 2006).  The statements were then 
transcribed into meaningful units or codes onto a separate document.  In doing so, I was 
able to cluster similar information to determine emerging categories and common 
patterns of evidence (Patton, 2002).  Using iterative collapsing, such categorical and 
patterned information, I repeatedly examined the data to reduce redundancy and 
repetition, and to connect the existing data across individual themes (Creswell, 2007, 
Maxwell, 2005).  Wertz et al. (2011) explained the existence of repetitive information 
allowed for generalization and the identification of commonalities, which then revealed 
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underlying concepts and the broader applicability the information has concerning the 
research topic.  Divergent information was also categorized and considered in the data 
analysis process.  Also, the absence of a specific theme did not imply the process was not 
thorough, but rather its omission or exclusion also served to inform the analytical process 
undertaking in qualitative analysis (Creswell, 2007). 
 The significant statements emerging from the clustered data provided the textural 
description of the effect of the pharmaceutical industry on rheumatologists’ patterns of 
patient care.  This process also encompassed the influencing contexts and settings that 
served to inform the study population’s lived experiences, thereby providing a structural 
description of the research topic as well.  Together, the textural and structural 
descriptions of the studied phenomenon form the essence of the study population’s shared 
experiences (Creswell, 2006).  Through the summarization of discovered themes and 
patterns, a composite summary was developed, which encompassed the delineated 
experiences of all research subjects, while also highlighting significant individual 
variations (Creswell, 2007; Maxwell, 2005; Patton, 2002; Wertz et al. (2011).   
Trustworthiness 
Credibility 
 In transcendental phenomenology, Moustakas (1994) described the credibility of 
research results should be uninfluenced by the investigator so as to accurately convey the 
lived experiences of the study participants.  Creswell (2006) and Patton (2002) further 
described validity in qualitative research requires thorough consideration of methodology, 
evidence gathering, and data interpretation processes.  Because I possessed a causal and 
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professional relationship with the research subjects, a passive influence may emanate 
during interviews, transcription and analysis (Maxwell, 2005).   
In order to address this inference, I employed bracketing to reduce individual bias 
and beliefs regarding the research content (Chan, Fung, & Chien, 2013).  This uniquely 
phenomenological approach allowed me the opportunity to alleviate my perceptions and 
prior knowledge of a given topic in order to solicit unbiased feedback from study subjects 
(Chan et al., 2013).  Additionally, to reduce such occurrences, I debriefed each subject 
following the conclusion of the interview to allow for summarization and additional 
participant feedback.  In doing so, each research subject had the opportunity to clarify, 
modify and verify the information gathered.  Morse (2012) and Moustakas (1994) 
referred to this process as a system of fact verification or member checking.    
Transferability 
Findings from this analysis included a rich description of the participants and the 
settings under evaluation.  The purpose of these characterizations was to allow external 
viewers the opportunity to transfer the study findings to other environments (Creswell, 
2006).  These shared attributes provided the necessary perspective for an external 
audience to consider potential variations, both from the targeted study population and the 
coexisting environment I shared with them (Moustakas, 1994).  Additionally, research 
assumptions described previously were central to the issue of trustworthiness.  
Particularly, study subjects were expected to have had previous exposure and experience 
with pharmaceutical agents, and therefore the transferability of these findings are limited 
to settings coexisting within similar boundaries (Maxwell, 2005).   
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Dependability 
 In parallel to the quantitative notion of reliability, trustworthiness in qualitative 
research findings requires dependability (Creswell, 2007; Guba, 1981; Patton, 2002; 
Wertz et al., 2011).  Guba’s (1981) description of dependability encompassed the totality 
of results, which would be inclusive of all variable situations encountered.  The 
variability of each subject’s responses was captured and thoroughly reviewed to ensure 
accurate transcription.  To ensure the dependability of the results obtained through this 
inquiry, I conducted a code-recode procedure.  Guba (1981) described this process as an 
initial coding step, followed by a re-code or repeat coding process.  As part of the data 
analysis fulfillment, recorded interviews were expeditiously transcribed following each 
subject engagement.  In addition, the information was recoded approximately one to two 
weeks following the initial coding.  In doing so, the findings from both coding sessions 
were compared and contrasted to strengthen the dependability of the final results. 
Confirmability 
 Patton (2002) expressed the need to establish confirmability for qualitative 
research in order to minimize personal bias and influence.  However, the investigator 
often constructs the research instruments and tools applied in qualitative research; often 
implying complete abrogation of individual beliefs or preferences is not entirely possible 
(Creswell, 2007).  In order to minimize this effect, Creswell (2007), Maxwell (2005), 
Patton (2002) and Wertz et al. (2011) stressed the need for the researcher to acknowledge 
personal predispositions and assumptions.  Such acknowledgements allow for critical 
assessment of the methodology and interpretations employed for this research.  The 
 
73 
assumptions, limitations and data analysis plan for this evaluation provided a requisite 
audit trail for analytical consideration and confirmability. 
  
Ethical Procedures 
 Ethical research practices are essential in qualitative and quantitative inquiry to 
ensure study integrity and to protect subject confidentiality (Bellenger et al.; Creswell, 
2007; Goertz & Mahoney, 2012; Guba, 1981; Maxwell, 2005; Moustakas, 1994; Patton 
2002).  To ensure subject protection and informed consent were obtained in a manner that 
ensured privacy and confidentiality, prior authorization to engage study participants was 
obtained through the Walden Investigational Review Board (IRB) prior to solicitation.  
Following approval of this research by the IRB, each subject was fully informed of the 
general purpose of the study through written and verbal communication, which were 
inclusive of the intent of the investigation and the interview process.  The consenting 
process commenced through email or face-to-face communication and explained the 
measures to ensure subject privacy and confidentiality.   
For this research, there were no expected risks associated with participating, 
which was strictly voluntary, and each subject was able to withdraw from the study at any 
time.  Research participants could refuse to answer any questions or expand explanations 
of existing interview questions if they deemed such exchange to be invasive.  Each 
candidate was informed that no form of compensation exists regarding his or her 
participation and the benefit associated with their voluntary consent resided in their 
ability to describe what effects the pharmaceutical industry had on their patient care.  
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Research subjects retained their consent form, which contained all of the relevant contact 
information for the researcher, IRB and other pertinent parties if they had questions or 
concerns at any time during the conduct of this study. 
 Subject confidentiality was maintained during the data analysis process through 
the assignment of subject numbers to protect the participant’s identity.  All audiotaped 
and transcribed data were maintained in a secure location by the investigator.  The 
electronic data was password protected and subject identifiers were only assessable by 
me.  No participant identification was provided in the dissemination of the data, but was 
rather coded to specific subject numbers not accessible by the reviewing audience.  Data 
will be archived for approximately 3 years, unless otherwise indicated by the Walden 
IRB. 
Summary 
 Understanding the impact the pharmaceutical industry may have on 
rheumatologists’ patterns of patient care was essential for improved collaborations 
between drug manufacturers, health care professionals, and the patients dependent upon 
the services provided by both entities.  Understanding the essence of the participant’s 
lived experiences regarding this topic dictated a phenomenological approach for inquiry.  
Though I professionally reside in the field of rheumatology and have experienced various 
interactions with the sampling population, individual preconceptions and past experiences 
were set-aside for the purposes of this research endeavor.   
Information saturation was obtained through the interactions of ten study subjects 
from various professional medical environments.  Interviews were the primary method of 
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information gathering and encompassed direct interactions between each subject and me.  
The interview protocol consisted of open-ended questions so as not to lead or guide 
participant feedback and to foster an open dialog necessary to capture the breadth and 
depth of information exchanged.  The interview protocol was designed by me and pilot 
tested to ensure validity and that the proposed dialog captured the intended information 
necessary to address the research question.   
Data collected during this investigation underwent a coding procedure to 
extrapolate emerging themes and phrases.  I transcribed audio taped interview 
conversations onto textural documentation and then derived a coding scheme that was 
rechecked through a secondary coding process.  The purpose of this data analysis 
procedure was to discern relevant words or phrases that expanded the understanding of 
the research question.  Discrepant or divergent information captured during the data 
collection process was also included in the analysis and coded separately from the other 
emerging themes. 
 Bracketing was employed to reduce potential bias and individual perceptions.  To 
increase credibility and validity of the emerging results, each subject was provided a 
debriefing following their interview to ensure the information captured accurately reflects 
their views and opinions.  Data analysis included a thorough description of the targeted 
study population and the individual environments in which they reside.  To this end, 
transferability can be implied through the lens of the intended audience for this research.  
Additionally, I provided the proposed assumptions and limitations of this research 
proactively to designate existing predispositions and to provide potential viewers the 
context in which this research was pursued. 
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 Lastly, various steps were undertaken to ensure subject privacy and 
confidentiality.  Approval from the Walden IRB and a thorough subject consenting 
process was indicated to safeguard the rights of each participating rheumatologist.  Each 
subject had these protections stated during the consenting process to validate their at will 
participation.  Data analysis and dissemination did not expose subject identities, but 
rather subject numbering provided the relevant information blinding.  Only I had access 
to the subject-level data and all study information was securely maintained on a 
password-protected computer to which only I had access.  
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Chapter 4: Presentation of Collection and Analysis 
 The focus of this phenomenological study was to explore the lived experiences of 
rheumatologists regarding the effect that the pharmaceutical industry has had on their 
patterns of patient care.  The following question guided this inquiry: 
1. What are rheumatologists’ lived experiences regarding the influence of the 
pharmaceutical industry on their pattern of patient care? 
Pilot Study 
 The purpose of the pilot study was to determine if the interview process facilitates 
the necessary dialog to answer the research question.  Following IRB approval of the 
research proposal, solicitations to several rheumatologists were made in order to secure 
appointments for study interviews.  Two specific rheumatologists, one in Georgia and the 
other in Alabama, were sent the protocol invitation (Appendix A); the participants agreed 
to participate in the pilot study and signed the study consent form (Appendix B).  Both 
participants of the pilot study were practicing rheumatologists with many similar 
characteristics of the larger, intended study population.  Both subjects were males over 
the age of 50.  Using the interview protocol (Appendix C), each rheumatologist provided 
abundant feedback.   
 Both interview transcripts were reviewed on two separate occasions.  Although 
both subjects provided multifarious feedback to each interview question, action words, 
commonalities in thought, and emphasis on relevant feelings were reiterated by both 
participants.  I used an inductive and iterative approach to determine whether these 
responses would address the over-arching research question.  The success of the pilot 
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study was determined by whether the feedback provided using the existing interview 
protocol adequately provided sufficient information to analyze the meaning and feelings 
rheumatologists have regarding the impact of their care by agents of the pharmaceutical 
industry.  In addition, the pilot study allowed me to challenge individual bias and to 
determine whether previous exposure with these individuals would influence their 
responses.   
 The objective of this study was to understand the lived experiences of 
rheumatologists regarding the effects that drug manufacturers have on their pattern of 
patient care.  Creswell (2007) explained that qualitative researchers seek to understand 
the meaning that individuals ascribe to a given situation or circumstance. Given the 
similarities provided by both subjects in the pilot study, generalizability was sufficiently 
obtained.  As such, the feasibility of this objective was satisfied in the pilot study, which 
allowed me to continue without modifications or alterations to the interview questions or 
protocol. 
Research Setting 
 As described in Chapter 3, subject recruitment for this research occurred in the 
states of Alabama, Florida, Georgia, and Mississippi.  Interviews for the 10 research 
participants, as well as the two included in the pilot study, occurred in each practitioner’s 
office.  Each subject meets with various agents of the pharmaceutical industry, including 
agents who sell products, medical information personnel, and clinical research associates.   
For the purposes of this research, each interview lasted between 10-35 minutes.  All 
sessions were interactive and allowed me opportunities to clarify statements and 
summarize information.   
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 All interviews were conducted as one-on-one engagements, free of other office 
personnel or additional agents from the pharmaceutical industry.  No interruptions 
occurred during any of the engagements.  Interviews were conducted in the physicians’ 
office at their clinics with their doors closed for privacy.  Most sessions occurred either 
before the rheumatologist began to see patients (early AM) or during lunchtime, when the 
physician would normally take a break from their clinic.  The only exception was a 
scheduled interview with one rheumatologist in the late afternoon. 
Demographics 
 Both rheumatologists participating in the pilot study were male.  Of the 10 
rheumatologists enrolling in the larger protocol, seven were male and three were female.  
The age range of these subjects was 43-75.  Three of the subjects were located in 
Alabama, two in Florida, and the remaining seven were in Georgia.  During the time of 
enrollment, I was able to schedule the above interviews prior to soliciting in the state of 
Mississippi.  One of the 10 participating subjects had an academic appointment, whereas 
the remaining rheumatologists were located in private practice settings.   
 Three of the 10 participants were in solo private practices, with all others being in 
larger practices with other rheumatologists.  One subject resided in a shared practice 
space with multiple rheumatologists and orthopedic medicine practitioners.  Eleven of the 
overall subjects were medical doctors (MD) specializing in rheumatology, and the 
remaining one practitioner was a doctor of osteopathic medicine (DO) specializing in 
rheumatology.  None of the participants presented any personal or organizational 
limitation that would impede their ability to enroll into this study. 
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Data Collection 
 Following approval from the Walden University IRB, solicitations for interviews 
were initially sent via e-mail.  After agreeing to enroll, the informed consent was 
presented to the participant during the interaction, and I explained their potential 
participation.  Once consent was obtained, interviews were conducted between July 2015 
and September 2015.  Each interview was conducted at the rheumatologist’s office and 
lasted approximately 10-30 minutes each.  The researcher-designed interview protocol 
(Appendix C) was validated in a pilot program in which two rheumatologists were 
interviewed regarding the effects pharmaceutical exposure has had on the care provided 
to their patients.  The feedback and responses obtained from the rheumatologists 
participating in the pilot interviews were used to validate the final interview protocol. 
 At the beginning of each interview, I explained the impartial nature of this inquiry 
and requested that subjects disregard any previous interactions involving my professional 
role.  During the interview process, each subject answered the questions in the interview 
protocol, and at the end of each interaction, I provided a brief summary.  Using Rubin 
and Rubin’s (2005) model, I offered open-ended questions, clarification statements, and 
standardized prompts when needed in order to understand the breadth and depth of the 
subject’s feedback.  No variations or deviations from the interview protocol were made 
during any of the 12 interviews. 
 Each interview was recorded using my password-protected model device.  The 
information contained in the recordings was quickly transcribed onto worded 
documentation.  Additionally, written notes were taken to ensure that all nonverbal 
behaviors were captured, which further allowed me the opportunity to clarify the feelings 
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of the subject.  All study-related documents were secured at my place of residence in a 
locked file cabinet.  All electronically recorded and transcribed documents were 
maintained on a password-protected personal computer also located at my home.  No 
unusual circumstances or interruptions were encountered during the interviews or data 
collection process. 
Data Analysis 
 I coded and categorized each worded transcript to identify the narrative elements 
serving as specific data points (Creswell, 2007; Wertz et al., 2011).  I employed 
Moustakas’ (1994) concept of horizonalization for data analysis, whereby significant 
statements made by the research participants were highlighted and then transcribed into 
meaningful units onto separate documents: one for each research question contained in 
the interview protocol.  Through the process of iterative collapsing, the categorical and 
patterned information was repeatedly examined to reduce redundancy and repetition and 
to connect the existing data across individual themes (Creswell, 2007; Maxwell, 2005).   
 Following this process, significant statements, action words, and pertinent phrases 
were categorized into positive, negative, and neutral themes.  As the first research 
question dealt with the types of interactions these subjects had with agents of the 
pharmaceutical industry, the primary responses clustered into scheduled and 
nonscheduled visits, and in-office or out-of-office circumstances.  The second research 
question inquired about the participant’s feelings regarding his or her experiences with 
individuals employed by drug manufacturers.  According to the primary theme emanating 
from this inquiry, the rheumatologists assessed each agent individually, as the majority of 
subjects answered this question initially as “it depends on the person.”  Within the 
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researched population, an equal amount of coded units were recorded for both positive 
and negative statements.  Positive inclinations involved statements such as “beneficial” 
and “camaraderie,” whereas negative statements included terms such as “conflicted” and 
“pressured.”  In several neutral statements, the subject’s feelings were influenced by the 
amount of time he or she had for each interaction and whether the information exchanged 
represented any specific “value.” 
 The third research question was used to assess rheumatologists’ perceptions of the 
products marketed to them by the pharmaceutical industry.  Similar to the second 
research question, many subjects indicated “it depends on the person.”  However, more 
negative units were recorded than positive.  Among the themes emerging from this 
inquiry, positive statements were more probable when subjects discussed “good” or 
“ethical relationships.”  The more resounding codes reflected “negative” or “deceptive 
relationships,” with several subjects specifically suggesting “biased” or “dishonest 
exchanges.”  More impartial clusters emanated from this inquiry than the previous 
questions, with increased references to rheumatologist’s “preference” and “knowledge.” 
 The fourth research question was used to describe what rheumatologists believed 
motivates the agents of drug companies who visit their centers.  All participants indicated 
“sales” as the major cluster theme.  Other neutral responses ensued, which included 
“establishing a rapport,” “they are under pressure,” and “maintaining access,” but several 
notable outliers suggested that pharmaceutical agents also “want to do a good job” and 
“want to educate physicians.”  Adversely, in negative clusters, the participants suggested 
that these agents “are dishonest,” “wrongfully interpret data,” and “are not transparent.”  
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Of note, three of the participating rheumatologists suggested that “sales” were the only 
motivation of these agents, with no further responses. 
 In Research Question 5, I sought to understand rheumatologists’ interpretation of 
the value of their interactions with drug representatives.  Contrary to the responses 
provided for Question four, clustered data for this examination were compellingly 
positive.  Ten of the 12 participating rheumatologists indicated “access support” was of 
particular value, supported by clustered statements like “providing samples,” “coupons 
for discounts,” and “patient education materials” were of benefit.  Additionally, subjects 
denoted the value of “efficacy and safety reminders,” “reference or data checking,” and 
“drug niches” as positive attributes of a quality interaction.  In fact, the only negative 
connotation was the reference of “low quality” interactions, suggesting that these 
exchanges had little or no value.  Several participants referenced the limitation of 
academic institutions that prevent interactions with agents of drug companies by 
providing neutral to negative statements.  Only private practice rheumatologists provided 
feedback regarding this issue and suggested that academic practitioners might limit their 
availability to valuable “drug information” and “access support” mechanisms.  No subject 
provided negative commentary regarding the academic center directly, but rather to the 
processes governing their interactions with pharmaceutical agents. 
 The final research question was used to explore how the experiences 
rheumatologists have had with drug agents have impacted the care provided to their 
patients.  Similar to Question 5, responses were overwhelmingly positive.  Specific 
emphasis on “access” was the primary theme, with many subjects indicating “samples” 
and “coupons” were important attributes of these agents.  Of note was the second most 
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common theme after clustering the data, which was “education exchange.”  All subjects 
indicated the need for continuous “education” and “keeping current” on new data.  
Though all rheumatologists provided positive statements, several suggested that the 
impact on their patient care was “minimal” or “very little.”  The primary neutral theme 
was similar to the other research questions, with several rheumatologists indicating that 
the impact on the care provided to their patients by agents of drug manufacturers 
“depended on the person.” 
 Discrepant information was captured and coded as well.  Two of the subjects 
indicated that they enjoy “hearing a different perspective” about a given drug and expect 
such exchanges when they engaged pharmaceutical personnel.  Two other 
rheumatologists stated that they often felt “guilty” if they had not used a drug and 
engaged an agent of that specific company.  Another participant indicated they “felt sorry” 
for these agents, specifically referring to the proposed pressures these agents undergo to 
facilitate the uptake of the product(s) they represent.  Lastly, one subject referenced 
meals and indicated “I cannot be bought with food,” suggesting that lunches provided by 
some of the pharmaceutical agents would not serve to influence their opinion of the drug 
the agent represented.  Although only one or two subjects offered these statements 
sporadically, the clustered data did not detract from underlying themes provided by each 
research question. 
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Evidence of Trustworthiness 
Credibility 
Because I had a professional relationship with the study subjects, ensuring 
credibility of these results will address this association and how I maintained impartiality 
(Patton, 2002).  Moustakas (1994) stated that the credibility of research results should be 
uninfluenced by the investigator so as to accurately convey the lived experiences of the 
study participants.  As described in Chapter 3, I had met the study subjects prior to 
interacting with them regarding this research pursuit.  Maxwell (2005) explained that a 
casual relationship between the researcher and the study population might introduce a 
passive influence during the interview process and analysis of the data.  In order to 
address this inference, I stressed the importance of being treated as a stranger during the 
interviews and employed bracketing to reduce individual bias and beliefs during data 
analysis (Chan et al., 2013).  In addition, I used fact verification and member checking 
during the interview process to ensure that the information exchanged was accurate and 
to provide the participant the opportunity to clarify any other statements (Morse, 2012; 
Moustakas, 1994).  
Transferability 
 Extensive data provided by the study participants provided robust descriptions of 
the lived experiences rheumatologists had with agents of the pharmaceutical industry.  
The characterizations and themes emerging from this research must be considered within 
the limits of the study as defined in Chapter 3.  Specifically, subjects were required to 
have had some history of interactions with pharmaceutical personnel, and transferability 
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to practitioners with little or no experience with such agents may not be possible.  
Additionally, the states included in subject recruitment included only Alabama, Florida, 
and Georgia.  Given the differences in access and managed care environments, 
transferability may be similar for rheumatologists residing in states with similar 
mechanisms, but different in locations with contrasting conditions.  For example, several 
U.S. states have limits on how much pharmaceutical companies can spend on lunches or 
other items, and the result may be fewer interactions with these agents.  Further, 
conditions outside the United States may be different in terms of access, governing laws, 
and potential exposure to such agents.  As such, transferability may occur only in similar 
environments as those presented in this research.  
Dependability 
 The trustworthiness of the results provided by this inquiry requires dependability 
(Creswell, 2007; Guba, 1981; Patton, 2002; Wertz et al., 2011).  Guba’s (1981) 
description of dependability encompasses the totality of results, which would be inclusive 
of all variable situations encountered.  All electronic interviews were transcribed to 
worded documents shortly following the actual engagement.  In addition to the initial 
transcription of the data, the information was recoded a second time (Guba, 1981).  The 
two coding sessions were then compared and contrasted to ensure that any emanating 
theme was not inadvertently omitted.  The findings from these two sessions were 
furthered clustered into meaningful statements and themes. 
Confirmability 
 Confirmability requires the researcher to minimize personal bias and reduce 
potential influence during exchanges with the study participants (Patton, 2002).  However, 
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Creswell (2007) explained that removing all potential bias is not entirely possible because 
the researcher is the primary tool capturing the data.  For the purposes of this inquiry, I 
explained during the consenting process that the rheumatologist should set aside previous 
experiences he or she may have had with me.  Additionally, it was stressed at the actual 
beginning of the interview process that the subjects treat me as a stranger, so as not to 
engage in any type of professional dialog or context removed from this investigation.  
Lastly, the coding process included a consistent review of each textual document without 
reflection of the subject involved, resulting in a document of clustered themes free of 
participant identifying information.   
Study Results 
This phenomenological study examined the effects of the pharmaceutical industry 
on rheumatologists’ patterns of patient care.   The research question sought to understand 
the feelings of the participating rheumatologists and the meaning their interactions with 
agents of drug manufacturers has had for them.  The interview protocol provided vast 
amounts of data for analytical consumption and provided the views of different 
rheumatologist located in different states.  The majority of interactions between research 
subjects and agents of the pharmaceutical industry occurred within the rheumatology 
practice site.  Scheduled and unscheduled interaction frequency occurred equally among 
the study population, with each rheumatologist indicating they allowed pharmaceutical 
representatives to provide lunch, and allowed these individuals the opportunity to drop in 
unannounced.  
Although study participants engaged drug personnel under these two conditions, 
the majority indicated their allocation of time for such interactions was limited by their 
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relationship with the individual and the amount of time they could offer.  The context of 
each subject’s relationship “depended on the pharmaceutical agent”, with numerous 
responses suggesting the opportunities they provided to the agent for engagement and the 
amount of time spent during the exchange was dependent on whether the practitioner 
liked or disliked the individual.  Other responses in this category included scheduled 
times spent with drug representatives, other than lunch or between patients, in which they 
provided time allocations for meetings.  Casual encounters with pharmaceutical 
personnel outside the office occurred rarely, with one third of the subjects indicating they 
occasionally attended industry-sponsored dinners.  Two subjects indicated personal 
friendships with agents of the pharmaceutical industry and his or her willingness to 
engage these individuals in a setting outside of the practice environment. 
Regarding rheumatologists’ feelings about their exchanges with drug personnel, 
the responses were mitigated by the same relationship criteria listed above.  If the 
rheumatologist liked the individual, the more willing they were to spend time with them 
and allow further access.  Conversely, if the agent was disliked, the rheumatologist was 
less likely to engage the agent and would cut the interaction short.  In responding to 
situations in which the pharmaceutical agent was liked, participants believed their 
exchanges brought value, credible insights, and camaraderie.  In conditions where the 
agent was disliked, the interactions were termed as awkward, defensive and brief.  
Importantly, several subjects noted their feelings regarding such interactions were 
influenced by the amount of time they could spend or were willing to spend with them.  
Through these exchanges, rheumatologists denoted unscheduled visits during peak 
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patient times lead to more negative connotations, even when the pharmaceutical agent 
was liked.   
 Regarding rheumatologists’ perceptions of the products sold by the various agents 
visiting their clinics, responses were influenced by the same relationship they had with 
the agent.  Most study participants provided statements affording some level of comfort 
regarding these agents if he or she was liked.  Within this contextual category, more than 
half of the rheumatologists indicated they engaged in primarily positive information 
exchanges with agents they previously developed comfort with.  These affirmative 
exchanges left the practitioners with greater contentment for prescribing a drug 
represented by these personnel.  Three of the rheumatologists provided more negative 
comments even when the agent was liked.  Specifically, themes of “deception” and 
“coercion” were documented suggesting these subjects believed representatives from 
drug manufacturers were obliged to sell their products regardless of the potential benefit 
or harm the drug may represent.  Lastly, three of the participants implied their opinions 
about the product in question directly influenced their perception of the agent 
representing that drug.   
 Unlike the previous responses to the preceding interview questions, subjects when 
asked about their opinions of what motivates these agents to visit their practices provided 
little variation.  The principle response from all rheumatologists suggested selling was the 
underlying motivation for these interactions.  However, some notable comments went 
beyond this influence and indicated information exchange and access were further goals 
of these agents.  Within this context, rheumatologists clearly saw agents of the 
pharmaceutical industry as vendors engaging in commerce and with goals to increase 
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potential transactions.  Several subjects acknowledged these agents are under pressure, 
and suggested this causality led them to use their products or to “spread the business 
around.”   Interestingly, all participants suggested these agents are part of the overall 
health care industry, citing “they have a job to do” and “I understand their role.” 
 Quickly following the discussion of motivations were statements regarding the 
value interactions may have for rheumatologists.  While still hinging on the perception 
the subject had on the agent of a drug manufacturer, responses were overwhelmingly 
positive.  Primarily, rheumatologists prefer scientific exchanges and information to help 
their patients access medications.  In fact, access related statements emerged during each 
interview and led to lengthy discussions regarding the potential benefits these agents can 
provide for practitioners.  Three of the rheumatologists specifically referred to academic 
centers and the lack of access related options because the institution may prohibit 
representatives from engaging doctors.  In regards to clinical exchanges between these 
agents and practitioners, subjects indicated understanding the “best use of a drug” or 
“access to resources” were the most common clusters of data.   
 With regards to pharmaceutical agents impacting the patient care provided by 
rheumatologists, “access to medications” was by far the most common response.  Many 
of the participants described situations in which their patients may lack funding or 
insurance necessary to procure a medication, and programs afforded by drug 
manufacturers were very helpful.  Specifically, “coupons”, “co-pay assistance”, and 
“access-support mechanisms” were most commonly cited.  All rheumatologists indicated 
positive information exchanges were beneficial and staying current on emerging 
medication research helped them make more comfortable decisions or made them more 
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confident regarding a given drug.  Two study subjects specifically indicated their 
perception regarding drug corporation’s impact on their patient care was either “minimal” 
or “had no effect.”  However, both participants provided additional dialog and indicated 
the same access related feedback provided by the other rheumatologists.  Only one 
subject indicated non-access related educational materials aimed directly at patients was 
helpful. 
Summary 
 The central research question posed by this research seeks to determine 
rheumatologists’ lived experiences regarding the influence of the pharmaceutical industry 
on their pattern of patient care.  The findings from this inquiry provided ample 
information regarding rheumatologists’ experiences with such agents and contribute to 
the growing body of evidence regarding the phenomenon under investigation.  Through 
the interview protocol I designed, exchanges with drug manufacturing personnel occur 
most frequently in the practitioner’s office, and many of these interactions were 
unscheduled.  Rheumatologist feelings regarding these exchanges crossed a wide 
spectrum of sentiment, with equal portions of both positive and negative statements.   
 The perception provided by the research subjects clearly seemed dependent on 
their relationship with the agent of the pharmaceutical industry.  Each participant 
provided statements similar to “it depends on the person” when answering the interview 
questions, meaning their social exchange value varied between different people.  
Invariably, this means the actual value of an exchange with a drug manufacturer 
employee encompassed the spectrum of purely scientific exchange to pleasantries to 
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annoyance.  Regarding the value of these social exchange situations for rheumatologists’ 
patients, almost all subjects referred to the greatest benefit being access-related 
discussions and educational materials facilitating the proper use of a given medication.   
 From this data, prevailing themes and concepts emerged to further advance this 
discussion and the overall understanding of the potential value exchanges between these 
matrix partners may represent.  As such, the interpretation of these results will be 
discussed in greater detail in the preceding chapter.  Furthermore, Chapter 5 will also 
discuss the research limitations, recommendations and implications of this body of 
evidence to further inform rheumatologists, pharmaceutical industry leadership, 
government regulatory agencies, managed care organizations, and patients as to the value 
of social exchange mechanisms between these associates. 
  
 
93 
Chapter 5: Summary, Conclusions, and Recommendations 
Each society must develop institutions to ensure the viability of its population.  
Health care is one such social institution, but it represents a complex blend of individuals, 
organizations, and governmental agencies.  Because the application of medical care 
involves multiple individuals engaging in a variety of exchanges in order to achieve a 
desired outcome, each may become influenced by the other over time (Blau, 1986).  
Although abundant research exists on the reciprocal relationship between health 
practitioners and agents of drug manufacturers (Appelbaum, 2010; Naik et al., 2009; 
Olsen & Whalen, 2009; Ritter, 2010), virtually no information exists within the specialty 
space of rheumatology.  Through the theoretical lens of social exchange, interactions 
among members of a given society often lead to reciprocal relationships, with each 
having potentially positive or negative outcomes.   
 It was necessary to explore the value-oriented interactions between 
pharmaceutical representatives and rheumatologists in order to determine the depth of 
influence one party has over the other.  Inevitably, such exchanges should serve to 
enhance patient care as both health care matrix partners occupy societal roles to maintain 
and improve medical outcomes.  Furthermore, drug manufacturers have developed 
organizational mission statements that aim to treat difficult diseases and help patients live 
longer, healthier lives (Kerridge et al., 2005; McClure, 2009).  Given the increased 
presence of pharmaceutical agents in rheumatology over the last decade, it is important to 
assess the potential impact these exchanges represent.  In this chapter, I examine the 
underlying meaning and interpretations of the lived experiences of rheumatologists’ 
 
94 
experiences with drug manufacturers and how such exchanges impact the care provided 
to their patients.  
Interpretation of the Findings 
 Through the examination of the lived experiences that rheumatologists had 
regarding their interactions with pharmaceutical agents, several key themes and trends 
emerged.   
Relationship 
 In each interview, I posed questions for rheumatologists to consider the value of 
exchanges with employees of drug manufacturers.  Universally, all subjects indicated that 
such interactions are expected and often desired.  Ekeh (1974) explained that the 
achievement of challenging goals often requires reciprocal relationships between multiple 
exchange partners.  Because these exchange partners coexist within a similar professional 
environment, like-minded tendencies, common interests, and a prevailing mission to 
fulfill their social role may form kinships and social bonds.  Blau (1986) explained that 
this phenomenon development is a result of reciprocal incentives created through various 
exchanges, resulting in growing interdependence between the individuals in the 
relationship.  From this perspective, it is logical to rationalize why subject responses 
regarded such relationships as “important,” “educational,” and “a necessary evil.” 
Within the United States most presiding laws, governmental regulations, and 
social norms often allow for interactions between medical practitioners and agents of the 
pharmaceutical industry.  A notable exception would be those academic centers having 
organizational conduct standards that, in some cases, restricts exchanges between these 
groups.  Several participants noted the lack of exchange potential for these environments, 
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and they noted that the reduced opportunity for interchange might deprive the physician 
of important patient assistant materials.  For those providing commentary regarding 
various academic restrictions, “access-related” materials were specifically indicated.  
Hence, rheumatologists believed that information and materials facilitating access to 
medications is an attribute that agents of the pharmaceutical companies may provide.  
Furthermore, “access” was a primary notation of subjects in this research and is an 
influential tool of the pharmaceutical industry. 
 Though all participants in this research engage in exchanges with employees of 
drug manufacturers, often on a daily basis, some relationships transcend the professional 
arena and develop into personal friendships.  Six of the 12 subjects specifically indicated 
that exchanges over time led to friendships and occasional nonprofessional engagement.  
Cook and Emerson (1987) explained that the social exchange spectrum often leads to 
necessary exchange partners, and these associations may result in kinships, which 
increase both partners’ avenues of social interchange.  Therefore, professional 
relationships are personal too, with both serving each participant’s goal-oriented 
behaviors.  Some subjects found profit in their friendships with agents of the 
pharmaceutical industry, often citing “camaraderie,” “respect,” and “trust” for such 
associations.  These rheumatologists noted that their friendly association did influence 
their willingness to spend time with such agents in and out of the office.  However, it was 
noted by each participate that providing such feedback did not impact their medical 
decision making.   
Four rheumatologists indicated that they consulted with pharmaceutical 
companies, most often in the capacity of a speaker/consultant.  These individuals were 
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more likely to have increased interactions with numerous types of pharmaceutical 
personnel.  Though all subjects indicated that their interactions were more frequent with 
pharmaceutical sales representatives, these rheumatologists indicated that they also 
interacted with medical, corporate executives, and research individuals at these 
companies.  When discussing their relationships with these expanded matrix members, 
subjects stated that such exchanges were positive and were more likely to provide 
educational value than exchanges with individuals associated directly with drug sales.  
Furthermore, this participant subset indicated that these relationships allowed them 
increased access to medical literature, clinical trial information, and in-depth medication 
knowledge. 
 All rheumatologists stated that their “relationship” dictated much of their 
interchange with pharmaceutical agents.  For each of the interview respondents, most 
subjects prefaced their response by stating, “it depends on the person.”  Thibaut (1986) 
indicated that exchange partners continuously assess the value of their interactions and 
seek to increase interchange with those who offer the greatest profit potential.  The 
rheumatologists were swayed by whether they liked the person.  These assessments 
seemed to have little or no influence by drug manufacturer association, but rather the on 
subject’s personal perception of the pharmaceutical individual.  Blau (1986) explained 
that this phenomenon is universally common because people often put personal 
preferences over professional pursuits.  Therefore, agents of drug manufacturers must 
often undergo a personal value appraisal by rheumatologists before their professional 
benefits can be assessed. 
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Respectfulness 
 Though a relationship and its resulting reliance have relative worth in exchange 
settings between agents of the pharmaceutical industry and practicing rheumatologists, 
these exchanges have limits.  Zhang and Epley (2009) explained that interchange partners 
seek to optimize exchange opportunities, but doing so often leads to developed protocols 
and expected conduct of action.  Within these processes, both parties set forth parameters 
in which to interact, but also became conditioned to accept terms from the other 
(Nakonenzy & Denton, 2008).  Failure to procure the remuneration of these exchanges 
could lead to conflict or abandonment (McNall & Roch, 2009).  In the case of this 
research, such boundaries would include a rheumatologist’s willingness to meet and the 
drug representative’s ability to demonstrate value within the exchange.  Given the 
subjectivity of the perceived value an agent of the pharmaceutical industry may provide, 
the drug maker representative’s ability to adjust to each customer type dictates a certain 
level of proficiency and respect. 
 During subject interviews, rheumatologists expected drug agents to respect their 
time and the confines in which they work.  Many participants suggested increased 
potential for negative outcomes when the practitioner was running late, was behind in 
examining patients, and when the pharmaceutical agent would not disengage in a timely 
manner.  The rheumatologist’s impression of the drug agent influenced such outcomes.  
Subjects were less likely to describe negative encounters with drug representatives when 
their exchanges were brief and to the point.  Therefore, it is likely to conclude that time is 
linked with the respect that rheumatologists have for the various pharmaceutical 
personnel they meet.   
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 Participants indicated various types of assessments used to determine the potential 
level of relative and absolute value of a drug representative.  Ten out of the 12 subjects 
suggested that agents who bring “value” and do “not waste their time” were more likely 
to enjoy open access and were more likely to have personal relationships with said person.  
Some of these personal relationships did include friendships and camaraderie, but most of 
this population segment referred more to their exchanges as “friendly” and “respectful.”  
Several rheumatologists provided stories of negative exchanges with agents they actually 
liked, but their personal predilections allowed the interchange to continue without 
abandonment.  Conversely, several subjects recalled positive exchanges with individuals 
they did not particularly like.  In both scenarios, respect was a common theme, acting in a 
reciprocal manner between both parties. 
 Examples of information and educational interaction occurred frequently between 
rheumatologists and pharmaceutical agents.  The appreciation of a given exchange was 
apparently influenced by the respect each had for the other and the amount of admiration 
given to the outcome of the transaction.  If the drug manufacturing personnel took only a 
small amount of time and provided something of high potential value, the individual’s 
access and opportunities for further exchange increased.  Given the vast 
institutionalization of drug innovation in the United States, these corporations have 
developed systematic social exchange approaches to market their products directly to 
health care professionals (Nakayama, 2008).  Blau (1986) indicated that the reciprocal 
relationship between two exchange parties creates alliances and the self-perpetuating 
requirement to continuously increase interchange possibilities.  Ekeh (1974) and Thibaut 
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(1986) explained that such relationships couldn’t exist without the confines of trust and 
respect.  
 Though pharmaceutical agents often demonstrate respect towards their 
rheumatology customers, 11 out of 12 subjects expressed that drug manufacturers’ 
motives for engaging them was to facilitate the prescribing of a particular drug.  However, 
the feedback provided on this topic was not solely exclusive to facilitating sales, but also 
included the perceived value of access support mechanisms and useful information 
exchanges.  When such interactions provided these positive attributes, the pharmaceutical 
agent was more likely to be seen as a “partner” and was allowed greater access.  Cook 
and Emerson (1987) expressed that the increased value of each exchange becomes a 
commodity in of itself and is worthy of respect and protection.  As such, drug agents 
providing useful information and not causing inconvenience, either through the duration 
of an exchange or the lack of pertinent content, were respected and valued by the 
rheumatologists participating in this research.   
Value Appraisal and Credibility 
 Value was a theme denoted by all research participants.  However, the relative or 
absolute value of a given exchange varied between subjects.  Social exchange equity is 
often disproportionate between interchange partners because one party may appraise a 
specific commodity differently than another (Blau, 1986).  Like other historical evidence 
of social exchange, the expense of a commodity in question must be known, understood, 
or tangible in order to apply remuneration (Thibaut, 1986).  Given the relative corporate 
goals of drug manufacturers to facilitate sales of their products, the absolute value from 
the practitioner’s viewpoint could be direct profit, educational enhancement, or improved 
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outcomes for their patients.  No study subject indicated directly or indirectly that 
individual profit was a motivation or outcome of his or her exchanges with agents of the 
pharmaceutical industry and, therefore, did not serve to influence their selection of a 
given drug over another. 
 Although wealth accumulation did not emerge as an influencing tactic employed 
by drug manufacturers, all 12 rheumatologists discussed information exchange and 
access-related activities.  As such, pharmaceutical agents sought to increase opportunities 
to facilitate both of these concepts.  In fact, most of the subjects indicated that their 
willingness to meet with such agents often lead to negative outcomes, but allowed the 
interaction to commence because of the possibility of positive exchange.  Ekeh (1974) 
denoted that individuals engaged in transactions are often willing to accept negative 
outcomes because the access to the opposing group may have future value.  Chen and 
Choi (2005) also explained that interchanges between trading partners may be financially 
motivated, but the relative worth of the exchange is often more valuable than the absolute 
commodity.  This philosophical concept may explain why rheumatologists are willing to 
meet with drug agents they are friendly with, but do not expect the interchange to result 
in any specific absolute value.  Conversely, rheumatologists may then meet with an 
individual they do not like because the potential exchange could potentially have relative 
value. 
 The most notable value of exchanges between rheumatologists and 
pharmaceutical agents was patient access-related materials or assistance.  Of the primary 
study population, all subjects denoted the importance of medication procurement for their 
patients.  Specific terms provided by this population included “insurance assistance,” 
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“coupons” and “copay assistance programs.”  Rheumatologists find value in their 
exchanges with drug manufacturing personnel when doing so facilitates the access of 
their drugs for the practitioner’s patients.  In fact, the only responses concerning financial 
exchange emanated from subject feedback about how pharmaceutical agents may be able 
to economically assist their patients.  When these comments emerged, specific reference 
to drug factory financial assistance programs were made. 
 Over half of this study population indicated that educational exchanges were 
beneficial.  However, the value assessment of these interactions encompassed the full 
spectrum of potential quality.  Three rheumatologists suggested that the majority of their 
informational exchanges with agents of the pharmaceutical industry were of low or no 
value.  Of note, the same three subjects denoted that their exchanges had no impact on 
their opinion of a given pharmaceutical organization or their patient treatment algorithms.  
Bignoux (2006) explained the effects of in-group pressures and how exchanges may 
occur when no absolute value is obtained.  It is the relative value of such interactions that 
may provide the motivation to engage another.  Cook and Emerson (1987) further 
explained this phenomenon by suggesting that one group may enter into an exchange 
with the sole purpose of educating the other, with the intent on future profit.  Within this 
concept, the initial party may wish to educate or prepare their exchange partner for future 
interchange, potentially leading to absolute value conversion over time. 
 For those remaining subjects indicating educational or informational exchange 
was of particular value, references were made to their enhancement of treatment 
knowledge and access.  Accordingly, exchanges encompassing new treatment 
information, potential population niches, and medication limitations of use (e.g., 
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reminders) were deemed to be of high value.  The outcomes of such reciprocity resulted 
in statements, such as “better educated,” “keeping up-to-date,” and “staying abreast of 
new information.”  Rheumatologists, therefore, expect their exchanges with agents of the 
pharmaceutical industry to achieve such goals periodically.  Although the inability to 
acquire such value occurred frequently among the participants’ exchanges, the majority 
indicated the potential for obtaining profit from their continuous interchanges outweighed 
the possible negative outcomes. 
Authority and Oversight 
 Previously discussed were the potential negative consequences of exchanges that 
presented little or no use for rheumatologists, but the prevailing norms governing such 
interactions requires closer examination.  Blau (1986), Cook and Emerson (1987), Ekeh 
(1974), and Thibaut (1986) explained how unstable social exchanges often lead to 
conflict and abrogation of future interchange, but are influenced by the prevailing social 
norms and social institutions overseeing a given activity.  As a result, social norms 
develop into an operative authority, which serve to limit instabilities and to ensure further 
exchange possibilities remain intact (Cook & Emerson, 1987).  Within these themes 
emerges a context for expectations, legitimacy, and authoritarian structure.  After 
synthesizing the data concerning interactions between rheumatologists and drug 
manufacturing personnel engagement, these practitioners expect appreciation for their 
time and value-based exchanges to improve the care provided to their patients.  The 
authoritarian parameters rheumatologists use to dictate potential positive encounters 
included “meeting with representatives only at scheduled times,” “meeting them only at 
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their clinic,” and disallowing exchanges when they believe the “individual or information 
is misguided.” 
 Of the primary study population, eight rheumatologists provided input regarding 
their preferred mechanisms of regulating interactions with pharmaceutical agents.  
Specific authoritarian statements used to describe these feelings included “on my turf,” “I 
have the advantage,” and “I don’t care what they think.”  Other less assertive descriptors 
included “I use my own filter,” “they send mixed messages,” and “lack of transparency.”  
The authority rheumatologists place over the individuals they meet with who are 
affiliated with drug manufacturers constitute the time allotment they are willing to invest, 
the location of the interaction, and their willingness to repudiate what was exchanged.  
According to this line of feedback, pharmaceutical agents conforming to a 
rheumatologist’s authoritative preferences were more likely to have greater access, more 
frequent exchanges, and improved informational correspondence.  
 In addition to the authoritative processes used by practicing rheumatologists, 
other distinct regulatory bodies were discussed.  Three subjects directly mentioned the 
“FDA” and “constricting pharmaceutical codes of conduct” as potential barriers to value 
exchanges between them and drug agents.  With regards to the FDA, the three 
respondents suggested “curtailing pharmaceutical personnel from discussing off-label 
uses of their products” (e.g., different diseases than what the drug is approved to treat) as 
a specific impediment to answering their questions regarding this issue.  One subject 
indicated the “FDA seeks to punish drug manufacturers that make quality products so as 
to serve as examples for other pharmaceutical corporations.”  Two other subjects 
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mentioned the FDA during their interviews, with both characterizing the rules this agency 
enforces when drug representatives engage practitioners.   
 In addition to regulatory oversight, four rheumatologists denoted the impediment 
of “pharmaceutical compliance practices” on their employees as a negative attribute.  
Within these discussions, participants suggested “pharmaceutical sales training” and 
“adherence to specific procedures” prevent their agents from providing value.  Examples 
of such practices were described as “inability to speak about off label drug use”, 
“protocols on who can and cannot be present during a specific discussion”, and that these 
representatives must “detail us with a sales message instead of assessing what we need.”  
Three rheumatologists directly linked these perceived hindrances with the inability for 
such agents to discuss important updates on patient access mechanisms and answering 
their specific drug related questions.  Access related discussions emerged in all subject 
interviews and were important to rheumatologists and the patients they treat. 
Rheumatologist’s Guidance 
Six of the ten participating rheumatologists provided feedback with the intention 
of improving interactions between themselves and pharmaceutical agents.  With regards 
to the types of interactions and a preferred location for exchanges, participants 
overwhelmingly recommended “in-office” encounters as their preferred venue.  Although 
several suggested “out-of-office” locales were permissible, each implied meeting away 
from their clinics was highly dependent on their time allotment and whether they liked 
the individual.  Within the same reference of individual appeal the subject had for a given 
drug agent, the rheumatologists was more likely to specify positive feelings and attitudes 
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towards the individual during an exchange.  Likewise, such agents were also deemed to 
be more credible and ethical, and were often allowed additional time with the practitioner. 
Perceptions of the pharmaceutical organizations and the personnel sent to engage 
rheumatologists encompassed a wide range of “likes” and “dislikes.”  Rheumatologists 
did not necessarily correlate their feelings towards the drug agent and the corporation 
they represent.  Instead, preference was given to the actual individual in question; with 
only two rheumatologists stating their attitudes regarding the agent was a “direct 
reflection” of their opinion of the company.  As such, the quality of each exchange 
seemed more influenced by the drug agent than the organization they represented.  Slight 
differing impressions were noted for rheumatologists’ opinions regarding the products 
associated with each pharmaceutical representative.  One third of the study population 
acknowledged their viewpoints regarding the drug representative “directly influenced” 
their perception of the drug they represented.  This indicated a high strategic value for the 
pharmaceutical agent and the types of exchanges they had with their rheumatology 
customers.  The same subjects indicated his or her “like” or “dislike” for the agent 
directly influenced whether they used the drug. 
The entire study population indicated they believed the primary motivation for 
sending drug manufacturing representatives to see them was “to facilitate sales.”  
However, two thirds of the rheumatologists also noted the importance of the “information 
exchange” as a specific benefit for them and their patients.  Although varied statements 
described the proposed benefit of this exchange, each indicated their willingness to 
continuously meet with pharmaceutical agents in the hopes that some of the exchanges 
would present particular value.  Such value was represented in statements like “new 
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updates”, ‘sampling’, “patient education”, and “unique perspectives.”  Therefore, it is 
logical to conclude rheumatologists were willing to see pharmaceutical agents, but 
expected some type of value based exchange to warrant their continued willingness to see 
the same person.  Four of the study participants specifically stated drug agents that “do 
not provide value”, but rather only “seek to fulfill organizational objectives” (i.e., 
corporate messaging) were more likely to be rejected or disinvited for future dialog. 
During the discussion of value acquisition for rheumatologists and their patients, 
four rheumatologists proactively suggested agents of the pharmaceutical industry “do not 
do enough to demonstrate their value to the larger society.”  Specifically, references were 
made towards “patient assistance programs” and “financial support mechanisms.”  One 
subject indicated they “could not understand why drug manufacturers would not advertise 
these programs directly to the public because doing so could facilitate greater use of their 
products.”  Given the fact medication access approaches were divulged by all subjects at 
some point during their interviews as a specific and paramount value set, the processes 
regarding how drug manufacturers derived and delivered this information for 
practitioners and the greater public could, and perhaps should, undergo additional 
scrutiny by leadership within the pharmaceutical industry. 
Limitations of the Study 
 This research examined the influence of pharmaceutical organizations on 
rheumatologists’ patterns of patient care.  As such, participants provided feedback from a 
rheumatologist’s perspective, and not from the aspect of the pharmaceutical industry or 
other institutional entity.  Although potential feedback provided by these organizations 
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and those employees who directly visit with rheumatologists would likely provide useful 
information and observations, such evaluation was beyond the scope of this research, but 
could further inform this growing body of knowledge.  Additionally, feedback provided 
by several subjects projected beyond the pharmaceutical industry and towards 
overarching regulatory agencies, but this too was not within the scope of this research 
examination.   
 Profit motives were not a specific pursuit of this research and the interview 
protocol was not designed to determine if such considerations directly influenced 
treatment choice.  Instead, this research sought to understand what influences were 
employed by pharmaceutical organizations to engage rheumatologists and how the target 
study population believed such engagements impacted the care provided to their patients.  
Nevertheless, when examining rheumatologist’s feelings about drug manufacturer 
marketing processes, direct monetary exchange between a pharmaceutical company and 
practitioner did not emerge from any discussions.  Appelbaum (2010), Cronstein (2007), 
Fischer et al. (2009) and Kerridge et al. (2005) each denoted the influence of financial 
incentives for practitioners were commonly used mechanisms employed by the 
pharmaceutical industry.  Although such evidence presided in other investigations similar 
to this topic, these and other types of financial influences cannot be absolutely dismissed 
in rheumatology.  However, no supporting evidence from this research emerged 
regarding individualistic profit motives. 
 This study population resided in the Southeastern United States.  Although 
rheumatology practices differ very little from state to state (American College of 
Rheumatology, 2012), regional differences may exist in more restrictive environments, 
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which seek to curtail interactions between the practitioners and agents of drug 
manufacturers.  Given the fact several states have enacted laws regarding physician and 
pharmaceutical industry interactions, the influences emanating from such exchanges may 
differ in these varied environments.  As such, the availability or frequency to meet with 
agents of drug manufacturers may differ from region to region and findings from this 
inquiry may not reflect rheumatologists’ opinions of potential pharmaceutical influence 
in areas where such interactions are highly restricted.  Additionally, only one 
academician enrolled in this research, providing limited insights on this practice setting.  
However, the dialog and statements provided by this individual differed very little from 
the other subjects, and no unique codes or outliers were derived during that interview.  
Nonetheless, this may present limitations on the transferability of these research findings 
for rheumatologists in academic settings. 
Recommendations 
 The findings from this research illustrated the various influences the 
pharmaceutical industry has on rheumatologists and the patients they treat.  
Overwhelming, evidence presented in this study suggests such influence was reliant on 
the individual pharmaceutical agent visiting rheumatologists’ offices and the possible 
impact made during their encounters.  Still, the value of exchanges between these two 
parties was inherently subjective, but the highest preference of rheumatologists was given 
to patient access mechanisms and processes to procure medication.  The goal of this 
research was to undercover what influences drug manufacturers have or use rather than 
categorically listing all possibilities, and given the fact patient access materials notably 
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resonated with rheumatologists, additional investigation as to the utility of these materials 
may be warranted. 
 Although rheumatologists indicated drug access materials were of particular 
importance, educational and informational exchanges occurred frequently.  Within these 
discussions, transactions resulting in positive or useful informational exchange were 
considered of particular value.  Furthermore, the consensus of this study population 
suggested these interactions were strongly desired and presented an opportunity for 
pharmaceutical companies to consider the educational value of the materials they used to 
engage this customer type.  Krumholz et al. (2009), McClure (2009), Naik et al. (2009) 
and Parker (2007) described the types of instructional materials used by pharmaceutical 
marketing campaigns, but lacked any specificity for rheumatologists.  Intrinsically, the 
actual types and descriptions of what educational exchange represented the highest value 
should guide and instruct additional research in this area.   
 Organizational structures and regions outside of this examination scope limited 
transferability of these findings.  As such, further scrutiny of other institutions interaction 
with rheumatologists would provide further insights as to their reciprocal relationships 
and how the pharmaceutical industry acted within that matrix.  Specifically, the FDA, 
academic institutions that limit interactions with drug agents, managed care organizations, 
and other third-party health care vendors (e.g., hospitals, accountable care organizations, 
etc.) each represented unique matrix partners for rheumatologists and such relationships 
may differ little or greatly between each pharmaceutical corporation.  Understanding the 
additional influences these organizations have could provide important opportunities for 
collaboration and partnership.  
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Implications 
 The United States health care system consists of many different individuals, 
organizations and regulatory agencies; all working collaboratively to ensure the 
application of health related services remains unimpaired.  Information exchange is a 
paramount necessity within these partnerships to assure fluidity and continuous 
improvement.  The pharmaceutical industry is one such matrix organization and requires 
various avenues in which to educate medical practitioners about their products.  Though 
regulation over this social institution by regulatory agencies has increased over the last 10 
years (Appelbaum, 2010; Crigger et al., 2008; Eichler et al., 2009), drug manufacturers 
are still largely permitted to exchange information with health care professionals.  Many 
therapeutic medical specialists have lengthy exposure to drug manufacturers, but 
rheumatologists have experienced an unprecedented rise in the rate of interactions with 
the pharmaceutical industry over the last decade. 
 Given the relatively limited time of exposure between these two social roles, 
investigation regarding the potential influence one has over the other allowed for 
increased transparency and opportunities for knowledge exchange to increase the 
potential impact of positive interchange.  Doing so could empower rheumatologists and 
drug manufacturers to improve processes and address areas of needed improvement.  
Because the potential for enhancements exists, the enriched fulfillment of their social 
roles to ensure the health of the societal population becomes realized.  Innovation in 
health care is an important condition for all civilizations because increased mortality and 
additional co-morbidities deprive that population of future advancements.  Though this 
research represented a relatively small investigation regarding the influences one health 
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care organization may have on another, its scope could be realized on a larger global 
level with additional rigorous investigation.   
 Within this inquiry, rheumatologists explained the specific tools and approaches 
that served to influence their opinions, behaviors, and the care provided to his or her 
patients.  Rheumatologists’ preferences and animosities suggested the pharmaceutical 
industry has options to both improve and curtain specific activities.  As such, both 
pharmaceutical leadership and rheumatologists have the opportunity to collaborate and 
use such findings to ameliorate processes that resulted in negative outcomes while 
optimizing positive mechanisms.  Doing so could lead to improved practitioner 
partnerships and potentially improve rheumatology patient outcomes.  A potential 
illustration of this improvement could be correlated to a specific rheumatological 
outcome.  The ACR indicates arthritic conditions are the leading cause of disability in the 
United States (American College of Rheumatology, 2012).  If a correlation between the 
qualitative improvements proposed in this research demonstrated a decrease in arthritic 
disability in the United States, the quantitative value of this inquiry would be realized.  
However, doing such an examination would require an entirely different scholarly 
approach and would, therefore, be out of the scope of this research. 
Conclusion  
 Given the relationship between a customer and merchant, power differentiation 
and social exchange mandates begins with the party having the greatest need.  
Pharmaceutical organizations need to market their products to appease organizational 
shareholders while rheumatologist must demonstrate value to their patients by improving 
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their health condition and preventing adverse medical outcomes.  Both exchange partners 
require the other to achieve these goals, but direct solicitation processes often resulted in 
agents of drug manufacturers proactively engaging rheumatologists to market their 
products.  As such, the influence pharmaceutical organizations wield over 
rheumatologists and the care provided to their patients is apparently limited, but multi-
faceted.    
 Pharmaceutical organizations demonstrated value in a variety of ways, such as 
medical access assistance, educational exchanges, access, and solidarity for their 
rheumatology customers.  In exchange, these practitioners expected interchange with 
agents of drug manufacturers and sought information exchange that enhanced their 
knowledge of medications and that was free of biased proclivity.  Although 
rheumatologists preferred such interactions, they often accepted negative social 
exchanges with the expectation future interchange would lead to positive outcomes.  In 
addition, many of the study participants developed kinships with these agents, often 
leading to fellowship and various levels of social bonds.  Through the medium of social 
exchange theory, such developments were expected between interchange members and 
served to enhance the bonds shared by each party (Blau, 1964; Cook & Emerson, 1987; 
Thibaut, 1986). 
 Opportunities for behavior modification and increased focus of valid educational 
content abound for the pharmaceutical industry as provided through the findings of this 
research.  Additionally, the quality and codes of conduct rheumatologists preferred from 
agents of drug manufacturers offered specific views on what this customer type expected 
and required in order to facilitate the care they provided to their patients.  Through the 
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synthesis of these outcomes, social exchange opportunities could be doubtlessly 
improved and the potential for improved patient outcomes became apparent.  
Fundamentally achieving these goals could benefit the larger society through more 
efficient procedures, enhancement of necessary medical knowledge, and advancement of 
population level health improvement. 
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Appendix A:  Introduction and Agreement to Participate Letter 
 
Frank Bailey, BMST(ASCP), MHA 
 
 
 
Date 
 
Re: Letter of Introduction 
 
Dear : 
 
I am a PhD student at Walden University’s School of Health Services Program and a full-
time employee of Bristol-Myers Squibb working in the Immunoscience division.  My 
research dissertation it titled The Pharmaceutical Industry’s Effect on Rheumatologist’s 
Patterns of Care.  The aim of this qualitative phenomenological study is to describe what 
effect rheumatologists believe drug manufacturers have had regarding the care they 
provide to their patients.   
 
In order to gather these perceptions and lived experiences, I will perform a semi-
structured interview, using the following research question: 
1. What are rheumatologists’ lived experiences regarding the influence of the 
pharmaceutical industry on their pattern of patient care? 
 
You have been selected as a potential candidate for this inquiry because you are a 
practicing rheumatologist who has experience in interacting with pharmaceutical 
personnel.  The significance of this study will be to articulate the possible impact drug 
manufacturers have had on rheumatologist’s care patterns for their patients in order for 
health care practitioners and drug manufacturing leadership to learn from this perspective 
and work toward equitable collaborations between vested stakeholders. 
 
The Walden University Institutional Review Board (IRB) has approved this research 
endeavor and will ensure the conduct of this research protects your identity and the 
integrity of the information gathered.  In order to assess your interest in participating in 
this research, I respectfully request you respond electronically to 
frank.bailey@waldenu.edu.  If you agree to participate, I will provide and IRB-approved 
consent form, which will provide more specifics regarding the conduct of this study. 
 
If you have any questions, I can be reached at the email address listed above or directly 
via cell phone at 404-217-2772. 
 
Respectfully, 
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Frank Bailey Walden University PhD Student 
Appendix B:  Consent Form 
 
A Phenomenological Investigation of the Pharmaceutical Industry’s Effect on 
Rheumatologist’s Patterns of Care.   
 
You are invited to participate in a research study that will examine the influence of drug 
manufacturers on rheumatologist’s care patterns.  The researcher is inviting 
rheumatologists who have experience in dealing with representatives of the drug 
manufacturing industry.  The purpose of this form is to obtain your consent to participate 
in the study and to provide you with an explanation of applicable study procedures and 
processes, so as to inform you of what to expect during the conduct of this research. 
 
This study is being conducted by Frank Bailey, a doctoral candidate at Walden University. 
 
Background Information: 
The purpose of this phenomenological study is to examine the effect the pharmaceutical 
industry has had on rheumatologist’s patterns of care.   
 
Procedures: 
If you agree to participate in this study, you will be asked to engage in an interview with 
the research for approximately 30-45 minutes.  The interview will be electronically 
recorded for transcription purposes by the researcher.  The researcher will provide a recap 
of the dialog upon completion of the interview to ensure the information captured 
accurately reflects your responses to the interview question.  You will not need to prepare 
for the interview, but rather share your thoughts, ideas and experiences regarding the 
protocol question. 
 
Voluntary Nature of the Study: 
Your participation in this research is strictly voluntary.  Your decision whether or not to 
participate will not affect your current or future relationship with the researcher or any 
pharmaceutical entity.  If you decide to participate, you are still free to withdraw at any 
time, without affecting those relationships.   
 
Risks and Benefits of Being in the Study: 
Being in this type of study involves some risk of the minor discomforts that can be 
encountered in daily life, such as minor every day risks involving anxiety or stress.  In the 
event you experience anxiety or stress during your participation in the study, you may 
terminate your participation at any time.  Participating in this study would not pose any 
risk to your safety or wellbeing. 
 
The potential benefits of this research will be the researcher’s ability to share information 
with other health care practitioners and pharmaceutical leadership regarding the effect 
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drug makers may have regarding the care provided by rheumatologists.  Understanding 
these ramifications may allow for increased collaboration between the pharmaceutical 
industry and health care practitioners, and/or facilitate positive processes that reflect 
equitable social exchange conduct. 
 
Payment: 
There will be no form of financial compensation, thank you gift, or reimbursement 
provided to you for your participation in this study.  The only benefit to you will be your 
ability to describe your experiences with agents of the pharmaceutical industry that have 
impacted your patient care. 
 
Confidentiality: 
Any information you provide will be kept strictly confidential.  The researcher will not 
use your personal information for any purposes outside of this research project.  Also, the 
investigator will not include your name or any other related information that could 
identify you or your organization in study reports.  Data will be maintained by the 
researcher in a locked file.  Data retention is expected to be 3 years, as required by the 
university, and then appropriately destroyed by the researcher. 
 
Contacts and Questions: 
The researcher conducting this study is Frank Bailey.  The researcher’s Walden faculty 
adviser is Lawrence Fulton, PhD, who can be reached at Lawrence.fulton@waldenu.edu.  
You may ask any questions you have now.  If you have questions later, you may contact 
the researcher at (mobile number) or at frank.bailey@waldenu.edu.  The Research 
Participant Advocate at Walden University is ______, and you may contact him/her at 
______, if you have questions regarding your participation in this study.  Walden 
University’s approval number for this research is _____ and it expires on _____. 
 
You will receive a copy of this form from the researcher. 
 
Statement of Consent: 
 
 I have read the above information.  I have asked questions and received answers.  I 
consent to participate in this study. 
 
Printed Name of Participant 
 ________________________________________________________ 
 
Participant Signature 
 ________________________________________________________ 
 
Signature of Investigator 
 ________________________________________________________ 
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Appendix C:  Interview Protocol 
Opening Prompt:  Let’s discuss your experiences regarding pharmaceutical 
interactions and its potential impact on patient care. 
 
What types of interactions do you have with agents of pharmaceutical organizations at 
your center? 
 
Do you have any interactions with pharmaceutical agents outside of your professional 
environment (e.g., church, neighbors, kid’s friends, etc.)? 
 
Tell me about how these interactions make you feel. 
 
What impact, if any, have these interactions had regarding your perceptions of the 
products these companies represent? 
 
Tell me what you believe motivates the various agents of drug manufacturers regarding 
their interactions with you. 
 
What value, if any, do you believe these interactions can have for you or your patients? 
 
Tell me how these experiences have impacted the care you provide to your patients. 
 
 
 
 
 
 
